# EDGAR Filing Document

**Accession Number:** 0000701985
**File Stem:** 0000701985-25-000030
**Filing Date:** 2025-8
**Character Count:** 128744
**Document Hash:** 6bf5d4b9e086f6c0eefa2004ba52e93c
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0000701985-25-000030.hdr.sgml**: 20250828

**ACCESSION NUMBER**: 0000701985-25-000030

**CONFORMED SUBMISSION TYPE**: 10-Q

**PUBLIC DOCUMENT COUNT**: 65

**CONFORMED PERIOD OF REPORT**: 20250802

**FILED AS OF DATE**: 20250828

**DATE AS OF CHANGE**: 20250828

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Bath & Body Works, Inc.
- **CENTRAL INDEX KEY:** 0000701985
- **STANDARD INDUSTRIAL CLASSIFICATION:** RETAIL-RETAIL STORES, NEC [5990]
- **ORGANIZATION NAME:** 07 Trade & Services
- **EIN:** 311029810
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 0131

**FILING VALUES:**
- **FORM TYPE:** 10-Q
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-08344
- **FILM NUMBER:** 251273918

**BUSINESS ADDRESS:**
- **STREET 1:** THREE LIMITED PKWY
- **STREET 2:** P O BOX 16000
- **CITY:** COLUMBUS
- **STATE:** OH
- **ZIP:** 43230
- **BUSINESS PHONE:** 6144157000

**MAIL ADDRESS:**
- **STREET 1:** THREE LIMITED PARKWAY
- **STREET 2:** P.O. BOX 16000
- **CITY:** COLUMBUS
- **STATE:** OH
- **ZIP:** 43230

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** L Brands, Inc.
- **DATE OF NAME CHANGE:** 20130322

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** LIMITED BRANDS INC
- **DATE OF NAME CHANGE:** 20020613

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** LIMITED INC
- **DATE OF NAME CHANGE:** 19920703

?xml version='1.0' encoding='ASCII'? bbwi-20250802

<u>[**Table of Contents**](#i6f3afdd0c78149d790c8cca7c8f4ba04_10)</u>

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**Washington, D.C. 20549**

_________________________________

**FORM 10-Q** 

_________________________________

**☒** **QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934**

**For the quarterly period ended August 2, 2025** 

**OR**

☐ **TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934**

**For the transition period from &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; to &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**

**Commission file number 1-8344** 

_________________________________

**BATH & BODY WORKS, INC.** 

**(Exact name of registrant as specified in its charter)**

_______________________________

---

| | | |
|:---|:---|:---|
| **Delaware** | | **31-1029810** |
| (State or other jurisdiction of<br>incorporation or organization) |  | (IRS Employer Identification No.) |
| **Three Limited Parkway** | **Three Limited Parkway** |  |
| **Columbus,** | **Ohio** | **43230** |
| (Address of principal executive offices) | (Address of principal executive offices) | (Zip Code) |
| **(614)** | **415-7000** | **415-7000** |
| (Registrant's telephone number, including area code) | (Registrant's telephone number, including area code) | (Registrant's telephone number, including area code) |
| **Not Applicable** | **Not Applicable** | **Not Applicable** |
| (Former name, former address and former fiscal year, if changed since last report) | (Former name, former address and former fiscal year, if changed since last report) | (Former name, former address and former fiscal year, if changed since last report) |

---

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.&nbsp;&nbsp;&nbsp;&nbsp;Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).&nbsp;&nbsp;&nbsp;&nbsp;Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer," "smaller reporting company," and "emerging growth company" in Rule 12b-2 of the Exchange Act.

---

| | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| Large accelerated filer | ☒ | Accelerated filer | ☐ | Smaller reporting company | **☐** | Non-accelerated filer | ☐ | Emerging growth company | **☐** |

---

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act.):&nbsp;&nbsp;&nbsp;&nbsp;Yes ☐&nbsp;&nbsp;&nbsp;&nbsp;No ☒

Securities registered pursuant to Section 12(b) of the Act:

---

| | | |
|:---|:---|:---|
| **Title of each class** | **Trading Symbol(s)** | **Name of each exchange on which registered** |
| Common Stock, $0.50 Par Value | BBWI | The New York Stock Exchange |

---

As of August 22, 2025, the number of outstanding shares of the Registrant's common stock was 206,187,576 shares.

------

<u>[**Table of Contents**](#i6f3afdd0c78149d790c8cca7c8f4ba04_10)</u>

**BATH & BODY WORKS, INC.®**

**TABLE OF CONTENTS**

---

| | |
|:---|:---|
| | **Page No.** |
| <u>[Part I. Financial Information](#i6f3afdd0c78149d790c8cca7c8f4ba04_13)</u> |  |
| &nbsp;&nbsp;&nbsp;Item 1. <u>[Financial Statements \*](#i6f3afdd0c78149d790c8cca7c8f4ba04_16)</u> |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>[Consolidated Statements of Income (Unaudited)](#i6f3afdd0c78149d790c8cca7c8f4ba04_19)</u> | <u>[3](#i6f3afdd0c78149d790c8cca7c8f4ba04_19)</u> |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>[Consolidated Statements of Comprehensive Income (Unaudited)](#i6f3afdd0c78149d790c8cca7c8f4ba04_19)</u> | <u>[3](#i6f3afdd0c78149d790c8cca7c8f4ba04_19)</u> |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>[Consolidated Balance Sheets as of](#i6f3afdd0c78149d790c8cca7c8f4ba04_22)[August 2](#i6f3afdd0c78149d790c8cca7c8f4ba04_22)[, 2025 (Unaudited), February 1, 2025 and](#i6f3afdd0c78149d790c8cca7c8f4ba04_22)[August 3](#i6f3afdd0c78149d790c8cca7c8f4ba04_22)[, 2024 (Unaudited)](#i6f3afdd0c78149d790c8cca7c8f4ba04_22)</u> | <u>[4](#i6f3afdd0c78149d790c8cca7c8f4ba04_22)</u> |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>[Consolidated Statements of Total Equity (Deficit) (Unaudited)](#i6f3afdd0c78149d790c8cca7c8f4ba04_25)</u> | <u>[5](#i6f3afdd0c78149d790c8cca7c8f4ba04_25)</u> |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>[Consolidated Statements of Cash Flows (Unaudited)](#i6f3afdd0c78149d790c8cca7c8f4ba04_31)</u> | <u>[7](#i6f3afdd0c78149d790c8cca7c8f4ba04_31)</u> |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>[Notes to Consolidated Financial Statements (Unaudited)](#i6f3afdd0c78149d790c8cca7c8f4ba04_34)</u> | <u>[8](#i6f3afdd0c78149d790c8cca7c8f4ba04_34)</u> |
| &nbsp;&nbsp;<u>[Report of Independent Registered Public Accounting Firm](#i6f3afdd0c78149d790c8cca7c8f4ba04_76)</u> | <u>[16](#i6f3afdd0c78149d790c8cca7c8f4ba04_76)</u> |
| &nbsp;&nbsp;<u>[Safe Harbor Statement Under the Private Securities Litigation Reform Act of 1995](#i6f3afdd0c78149d790c8cca7c8f4ba04_79)</u> | <u>[17](#i6f3afdd0c78149d790c8cca7c8f4ba04_79)</u> |
| &nbsp;&nbsp;&nbsp;Item 2. <u>[Management's Discussion and Analysis of Financial Condition and Results of Operations](#i6f3afdd0c78149d790c8cca7c8f4ba04_82)</u> | <u>[17](#i6f3afdd0c78149d790c8cca7c8f4ba04_82)</u> |
| &nbsp;&nbsp;&nbsp;Item 3. <u>[Quantitative and Qualitative Disclosures About Market Risk](#i6f3afdd0c78149d790c8cca7c8f4ba04_103)</u> | <u>[27](#i6f3afdd0c78149d790c8cca7c8f4ba04_103)</u> |
| &nbsp;&nbsp;&nbsp;Item 4. <u>[Controls and Procedures](#i6f3afdd0c78149d790c8cca7c8f4ba04_106)</u> | <u>[28](#i6f3afdd0c78149d790c8cca7c8f4ba04_106)</u> |
| <u>[Part II. Other Information](#i6f3afdd0c78149d790c8cca7c8f4ba04_109)</u> | <u>[29](#i6f3afdd0c78149d790c8cca7c8f4ba04_109)</u> |
| &nbsp;&nbsp;&nbsp;Item 1. <u>[Legal Proceedings](#i6f3afdd0c78149d790c8cca7c8f4ba04_112)</u> | <u>[29](#i6f3afdd0c78149d790c8cca7c8f4ba04_112)</u> |
| &nbsp;&nbsp;&nbsp;Item 1A. <u>[Risk Factors](#i6f3afdd0c78149d790c8cca7c8f4ba04_115)</u> | <u>[29](#i6f3afdd0c78149d790c8cca7c8f4ba04_115)</u> |
| &nbsp;&nbsp;&nbsp;Item 2. <u>[Unregistered Sales of Equity Securities and Use of Proceeds](#i6f3afdd0c78149d790c8cca7c8f4ba04_118)</u> | <u>[29](#i6f3afdd0c78149d790c8cca7c8f4ba04_118)</u> |
| &nbsp;&nbsp;&nbsp;Item 3. <u>[Defaults Upon Senior Securities](#i6f3afdd0c78149d790c8cca7c8f4ba04_121)</u> | <u>[29](#i6f3afdd0c78149d790c8cca7c8f4ba04_121)</u> |
| &nbsp;&nbsp;&nbsp;Item 4. <u>[Mine Safety Disclosures](#i6f3afdd0c78149d790c8cca7c8f4ba04_124)</u> | <u>[29](#i6f3afdd0c78149d790c8cca7c8f4ba04_124)</u> |
| &nbsp;&nbsp;&nbsp;Item 5. <u>[Other Information](#i6f3afdd0c78149d790c8cca7c8f4ba04_127)</u> | <u>[29](#i6f3afdd0c78149d790c8cca7c8f4ba04_127)</u> |
| &nbsp;&nbsp;&nbsp;Item 6. <u>[Exhibits](#i6f3afdd0c78149d790c8cca7c8f4ba04_133)</u> | <u>[30](#i6f3afdd0c78149d790c8cca7c8f4ba04_133)</u> |
| <u>[Signature](#i6f3afdd0c78149d790c8cca7c8f4ba04_136)</u> | <u>[31](#i6f3afdd0c78149d790c8cca7c8f4ba04_136)</u> |

---

\* The Company's fiscal year ends on the Saturday nearest to January 31. As used herein, "second quarter of 2025" and "second quarter of 2024" refer to the thirteen-week periods ended August 2, 2025 and August 3, 2024, respectively. "Year-to-date 2025" and "year-to-date 2024" refer to the twenty-six-week periods ended August 2, 2025 and August 3, 2024, respectively.

------

<u>[**Table of Contents**](#i6f3afdd0c78149d790c8cca7c8f4ba04_10)</u>

**PART I—FINANCIAL INFORMATION**

**Item 1. FINANCIAL STATEMENTS**

**BATH & BODY WORKS, INC.**

**CONSOLIDATED STATEMENTS OF INCOME**

**(in millions, except per share amounts)**

**(Unaudited)**

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Second Quarter** | **Second Quarter** | **Year-to-Date** | **Year-to-Date** |
| | **2025** | **2024** | **2025** | **2024** |
| Net Sales | $1549 | $1526 | $2974 | $2910 |
| Costs of Goods Sold, Buying and Occupancy | (909) | (900) | (1687) | (1677) |
| Gross Profit | 640 | 626 | 1287 | 1233 |
| General, Administrative and Store Operating Expenses | (483) | (443) | (920) | (863) |
| Operating Income | 157 | 183 | 367 | 370 |
| Interest Expense | (68) | (77) | (139) | (159) |
| Other Income, Net | 6 | 47 | 13 | 61 |
| Income Before Income Taxes | 95 | 153 | 241 | 272 |
| Provision for Income Taxes | (31) | (1) | (72) | (33) |
| Net Income | $64 | $152 | $169 | $239 |
| Net Income per Basic Share | $0.31 | $0.68 | $0.80 | $1.07 |
| Net Income per Diluted Share | $0.30 | $0.68 | $0.79 | $1.06 |

---

**BATH & BODY WORKS, INC.**

**CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME**

**(in millions)**

**(Unaudited)**

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Second Quarter** | **Second Quarter** | **Year-to-Date** | **Year-to-Date** |
| | **2025** | **2024** | **2025** | **2024** |
| Net Income | $64 | $152 | $169 | $239 |
| Other Comprehensive Income (Loss), Net of Tax: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Foreign Currency Translation |  | (1) | 6 | (3) |
| &nbsp;&nbsp;&nbsp;&nbsp;Unrealized Gain (Loss) on Cash Flow Hedges |  | 1 | (3) | 2 |
| &nbsp;&nbsp;&nbsp;&nbsp;Reclassification of Cash Flow Hedges to Earnings |  |  | (1) |  |
| Total Other Comprehensive Income (Loss), Net of Tax |  |  | 2 | (1) |
| Total Comprehensive Income | $64 | $152 | $171 | $238 |

---

The accompanying Notes are an integral part of these Consolidated Financial Statements.

------

<u>[**Table of Contents**](#i6f3afdd0c78149d790c8cca7c8f4ba04_10)</u>

**BATH & BODY WORKS, INC.**

**CONSOLIDATED BALANCE SHEETS**

**(in millions, except par value amounts)**

---

| | | | |
|:---|:---|:---|:---|
| | **August 2,<br>2025** | **February 1,<br>2025** | **August 3,<br>2024** |
| | **(Unaudited)** | | **(Unaudited)** |
| **ASSETS** | | | |
| Current Assets: |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Cash and Cash Equivalents | $364 | $674 | $514 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accounts Receivable, Net | 131 | 205 | 146 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Inventories | 977 | 734 | 863 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Easton Assets Held for Sale | 81 | 96 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other | 153 | 114 | 143 |
| Total Current Assets | 1706 | 1823 | 1666 |
| Property and Equipment, Net | 1124 | 1127 | 1166 |
| Operating Lease Assets | 984 | 949 | 1043 |
| Goodwill | 628 | 628 | 628 |
| Trade Name | 165 | 165 | 165 |
| Deferred Income Taxes | 133 | 130 | 143 |
| Other Assets | 74 | 50 | 137 |
| Total Assets | $4814 | $4872 | $4948 |
| **LIABILITIES AND EQUITY (DEFICIT)** |  |  |  |
| Current Liabilities: |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accounts Payable | $567 | $338 | $411 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accrued Expenses and Other | 541 | 584 | 526 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Current Debt |  |  | 313 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Current Operating Lease Liabilities | 194 | 192 | 186 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Income Taxes | 1 | 117 | 61 |
| Total Current Liabilities | 1303 | 1231 | 1497 |
| Deferred Income Taxes | 23 | 24 | 45 |
| Long-term Debt | 3888 | 3884 | 3881 |
| Long-term Operating Lease Liabilities | 912 | 883 | 984 |
| Other Long-term Liabilities | 235 | 233 | 259 |
| Shareholders' Equity (Deficit): |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Preferred Stock - $1.00 par value; 10 shares authorized; none issued |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Common Stock - $0.50 par value; 1,000 shares authorized; 223, 231 and 235 shares issued; 208, 216 and 220 shares outstanding, respectively | 111 | 115 | 117 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Paid-in Capital | 806 | 829 | 830 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accumulated Other Comprehensive Income | 73 | 71 | 74 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Retained Earnings (Accumulated Deficit) | (1716) | (1578) | (1918) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Less: Treasury Stock, at Average Cost; 15, 15 and 15 shares, respectively | (822) | (822) | (822) |
| Total Shareholders' Equity (Deficit) | (1548) | (1385) | (1719) |
| Noncontrolling Interest | 1 | 2 | 1 |
| Total Equity (Deficit) | (1547) | (1383) | (1718) |
| Total Liabilities and Equity (Deficit) | $4814 | $4872 | $4948 |

---

The accompanying Notes are an integral part of these Consolidated Financial Statements.

------

<u>[**Table of Contents**](#i6f3afdd0c78149d790c8cca7c8f4ba04_10)</u>

**BATH & BODY WORKS, INC.**

**CONSOLIDATED STATEMENTS OF TOTAL EQUITY (DEFICIT)**

**(in millions, except per share amounts)**

**(Unaudited)**

**Second Quarter 2025** 

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | **Common Stock** | **Common Stock** | **Paid-In<br>Capital** | **Accumulated<br>Other<br>Comprehensive<br>Income** | **Retained<br>Earnings (Accumulated Deficit)** | **Treasury<br>Stock, at<br>Average<br>Cost** | **Noncontrolling Interest** | **Total Equity (Deficit)** |
| | **Shares<br>Outstanding** | **Par<br>Value** | **Paid-In<br>Capital** | **Accumulated<br>Other<br>Comprehensive<br>Income** | **Retained<br>Earnings (Accumulated Deficit)** | **Treasury<br>Stock, at<br>Average<br>Cost** | **Noncontrolling Interest** | **Total Equity (Deficit)** |
| **Balance, May 3, 2025** | 212 | $113 | $818 | $73 | $(1633) | $(822) | $1 | $(1450) |
| Net Income |  |  |  |  | 64 |  |  | 64 |
| Other Comprehensive Income |  |  |  |  |  |  |  |  |
| Total Comprehensive Income |  |  |  |  | 64 |  |  | 64 |
| Cash Dividends ($0.20 per share) |  |  |  |  | (42) |  |  | (42) |
| Repurchases of Common Stock | (4) |  |  |  |  | (121) |  | (121) |
| Treasury Share Retirement |  | (2) | (14) |  | (105) | 121 |  |  |
| Share-based Compensation and Other |  |  | 2 |  |  |  |  | 2 |
| **Balance, August 2, 2025** | 208 | $111 | $806 | $73 | $(1716) | $(822) | $1 | $(1547) |

---

**Second Quarter 2024** 

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | **Common Stock** | **Common Stock** | **Paid-In<br>Capital** | **Accumulated<br>Other<br>Comprehensive<br>Income** | **Retained<br>Earnings (Accumulated Deficit)** | **Treasury<br>Stock, at<br>Average<br>Cost** | **Noncontrolling Interest** | **Total Equity (Deficit)** |
| | **Shares<br>Outstanding** | **Par<br>Value** | **Paid-In<br>Capital** | **Accumulated<br>Other<br>Comprehensive<br>Income** | **Retained<br>Earnings (Accumulated Deficit)** | **Treasury<br>Stock, at<br>Average<br>Cost** | **Noncontrolling Interest** | **Total Equity (Deficit)** |
| **Balance, May 4, 2024** | 223 | $119 | $841 | $74 | $(1889) | $(822) | $1 | $(1676) |
| Net Income |  |  |  |  | 152 |  |  | 152 |
| Other Comprehensive Income |  |  |  |  |  |  |  |  |
| Total Comprehensive Income |  |  |  |  | 152 |  |  | 152 |
| Cash Dividends ($0.20 per share) |  |  |  |  | (45) |  |  | (45) |
| Repurchases of Common Stock | (4) |  |  |  |  | (150) |  | (150) |
| Treasury Share Retirement |  | (2) | (12) |  | (136) | 150 |  |  |
| Share-based Compensation and Other | 1 |  | 1 |  |  |  |  | 1 |
| **Balance, August 3, 2024** | 220 | $117 | $830 | $74 | $(1918) | $(822) | $1 | $(1718) |

---

The accompanying Notes are an integral part of these Consolidated Financial Statements.

------

<u>[**Table of Contents**](#i6f3afdd0c78149d790c8cca7c8f4ba04_10)</u>

**BATH & BODY WORKS, INC.**

**CONSOLIDATED STATEMENTS OF TOTAL EQUITY (DEFICIT)**

**(in millions, except per share amounts)**

**(Unaudited)**

**Year-to-Date 2025** 

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | **Common Stock** | **Common Stock** | **Paid-In<br>Capital** | **Accumulated<br>Other<br>Comprehensive<br>Income** | **Retained<br>Earnings (Accumulated Deficit)** | **Treasury<br>Stock, at<br>Average<br>Cost** | **Noncontrolling Interest** | **Total Equity (Deficit)** |
| | **Shares<br>Outstanding** | **Par<br>Value** | **Paid-In<br>Capital** | **Accumulated<br>Other<br>Comprehensive<br>Income** | **Retained<br>Earnings (Accumulated Deficit)** | **Treasury<br>Stock, at<br>Average<br>Cost** | **Noncontrolling Interest** | **Total Equity (Deficit)** |
| **Balance, February 1, 2025** | 216 | $115 | $829 | $71 | $(1578) | $(822) | $2 | $(1383) |
| Net Income |  |  |  |  | 169 |  |  | 169 |
| Other Comprehensive Income |  |  |  | 2 |  |  |  | 2 |
| Total Comprehensive Income |  |  |  | 2 | 169 |  |  | 171 |
| Cash Dividends ($0.40 per share) |  |  |  |  | (85) |  |  | (85) |
| Repurchases of Common Stock | (8) |  |  |  |  | (256) |  | (256) |
| Treasury Share Retirement |  | (4) | (30) |  | (222) | 256 |  |  |
| Share-based Compensation and Other |  |  | 7 |  |  |  | (1) | 6 |
| **Balance, August 2, 2025** | 208 | $111 | $806 | $73 | $(1716) | $(822) | $1 | $(1547) |

---

**Year-to-Date 2024** 

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | **Common Stock** | **Common Stock** | **Paid-In<br>Capital** | **Accumulated<br>Other<br>Comprehensive<br>Income** | **Retained<br>Earnings (Accumulated Deficit)** | **Treasury<br>Stock, at<br>Average<br>Cost** | **Noncontrolling Interest** | **Total Equity (Deficit)** |
| | **Shares<br>Outstanding** | **Par<br>Value** | **Paid-In<br>Capital** | **Accumulated<br>Other<br>Comprehensive<br>Income** | **Retained<br>Earnings (Accumulated Deficit)** | **Treasury<br>Stock, at<br>Average<br>Cost** | **Noncontrolling Interest** | **Total Equity (Deficit)** |
| **Balance, February 3, 2024** | 225 | $120 | $838 | $75 | $(1838) | $(822) | $1 | $(1626) |
| Net Income |  |  |  |  | 239 |  |  | 239 |
| Other Comprehensive Loss |  |  |  | (1) |  |  |  | (1) |
| Total Comprehensive Income |  |  |  | (1) | 239 |  |  | 238 |
| Cash Dividends ($0.40 per share) |  |  |  |  | (90) |  |  | (90) |
| Repurchases of Common Stock | (6) |  |  |  |  | (249) |  | (249) |
| Treasury Share Retirement |  | (3) | (17) |  | (229) | 249 |  |  |
| Share-based Compensation and Other | 1 |  | 9 |  |  |  |  | 9 |
| **Balance, August 3, 2024** | 220 | $117 | $830 | $74 | $(1918) | $(822) | $1 | $(1718) |

---

The accompanying Notes are an integral part of these Consolidated Financial Statements.

------

<u>[**Table of Contents**](#i6f3afdd0c78149d790c8cca7c8f4ba04_10)</u>

**BATH & BODY WORKS, INC.**

**CONSOLIDATED STATEMENTS OF CASH FLOWS**

**(in millions)**

**(Unaudited)**

---

| | | |
|:---|:---|:---|
| | **Year-to-Date** | **Year-to-Date** |
| | **2025** | **2024** |
| **Operating Activities:** |  |  |
| Net Income | $169 | $239 |
| Adjustments to Reconcile Net Income to Net Cash Provided by Operating Activities: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Depreciation of Long-lived Assets | 128 | 142 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Share-based Compensation Expense | 18 | 22 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Gain on Sales of Easton Investments |  | (39) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Deferred Income Taxes | (1) | (102) |
| Changes in Assets and Liabilities: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accounts Receivable | 75 | 78 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Inventories | (241) | (154) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accounts Payable, Accrued Expenses and Other | 157 | (67) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Income Taxes Payable | (139) | (79) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other Assets and Liabilities | (21) | (10) |
| Net Cash Provided by Operating Activities | 145 | 30 |
| **Investing Activities:** |  |  |
| Capital Expenditures | (93) | (101) |
| Proceeds from Sales of Easton Investments |  | 50 |
| Other Investing Activities | (2) | 11 |
| Net Cash Used for Investing Activities | (95) | (40) |
| **Financing Activities:** |  |  |
| Payments for Long-term Debt |  | (202) |
| Repurchases of Common Stock | (254) | (248) |
| Dividends Paid | (85) | (90) |
| Tax Payments Related to Share-based Awards | (8) | (15) |
| Other Financing Activities | (15) | (5) |
| Net Cash Used for Financing Activities | (362) | (560) |
| Effects of Exchange Rate Changes on Cash and Cash Equivalents | 2 |  |
| Net Decrease in Cash and Cash Equivalents | (310) | (570) |
| Cash and Cash Equivalents, Beginning of Year | 674 | 1084 |
| Cash and Cash Equivalents, End of Period | $364 | $514 |

---

The accompanying Notes are an integral part of these Consolidated Financial Statements.

------

<u>[**Table of Contents**](#i6f3afdd0c78149d790c8cca7c8f4ba04_10)</u>

**BATH & BODY WORKS, INC.**

**NOTES TO CONSOLIDATED FINANCIAL STATEMENTS**

**(Unaudited)**

**1. Description of Business and Basis of Presentation**

***Description of Business***

Bath & Body Works, Inc. (the "Company") is a global omnichannel retailer focused on personal care and home fragrance. The Company sells merchandise through its retail stores in the United States of America ("U.S.") and Canada, and through its websites and other channels, under the Bath & Body Works®, White Barn® and other brand names. The Company's international business is conducted through franchise, license and wholesale partners.

***Fiscal Year***

The Company's fiscal year ends on the Saturday nearest to January 31. As used herein, "second quarter of 2025" and "second quarter of 2024" refer to the thirteen-week periods ended August 2, 2025 and August 3, 2024, respectively. "Year-to-date 2025" and "year-to-date 2024" refer to the twenty-six-week periods ended August 2, 2025 and August 3, 2024, respectively. References to "quarter" and "year" each refer to the fiscal calendar period.

***Basis of Consolidation***

The Consolidated Financial Statements include the accounts of the Company and its subsidiaries. All significant intercompany balances and transactions have been eliminated in consolidation. The Company accounts for investments in unconsolidated entities where it exercises significant influence, but does not have control, using the equity method. Under the equity method of accounting, the Company recognizes its share of the investee's net income or loss. Losses are only recognized to the extent the Company has positive carrying value related to the investee. Carrying values are only reduced below zero if the Company has an obligation to provide funding to the investee. The Company's share of net income or loss of all unconsolidated entities is included in Other Income, Net in the Consolidated Statements of Income. The Company's equity method investments are required to be reviewed for impairment when it is determined there may be an other-than-temporary loss in value.

***Interim Financial Statements***

The Consolidated Financial Statements as of and for the periods ended August 2, 2025 and August 3, 2024 are unaudited and are presented pursuant to the rules and regulations of the Securities and Exchange Commission. These Consolidated Financial Statements should be read in conjunction with the Consolidated Financial Statements and Notes thereto contained in the Company's 2024 Annual Report on Form 10-K.

In the opinion of management, the accompanying Consolidated Financial Statements reflect all adjustments that are of a normal recurring nature and necessary for a fair presentation of the results for the interim periods.

***Seasonality of Business***

The Company's operations are seasonal in nature and consist of two principal selling seasons: Spring (the first and second quarters) and Fall (the third and fourth quarters). Typically, the Company's sales are highest during the fourth quarter of the fiscal year due to seasonal and holiday-related sales patterns. Due to the seasonal variations in the retail industry, the results of operations for the interim periods are not necessarily indicative of the results expected for the full fiscal year.

***Derivative Financial Instruments***

The Company's Canadian dollar denominated earnings are subject to exchange rate risk as substantially all the Company's merchandise sold in Canada is sourced through U.S. dollar transactions. The Company uses foreign currency forward contracts designated as cash flow hedges to mitigate this foreign currency exposure. Amounts are reclassified from Accumulated Other Comprehensive Income upon sale of the hedged merchandise to the customer. These gains and losses are recognized in Costs of Goods Sold, Buying and Occupancy in the Consolidated Statements of Income. All designated cash flow hedges are recorded on the Consolidated Balance Sheets at fair value. The fair value of designated cash flow hedges is not significant for any period presented. The Company does not use derivative financial instruments for trading purposes.

***Supplier Finance Program***

In the fourth quarter of 2024, the Company implemented a supply chain finance ("SCF") program agreement with a third-party financial institution, whereby the Company's merchandise suppliers have the opportunity to settle outstanding payment obligations early, at a discount, facilitated by the financial institution. The Company's obligations to its suppliers, including amounts due and scheduled payment terms, are not impacted by suppliers' participation in the arrangement and the Company provides no guarantees to any third parties under the SCF program. Amounts due under the SCF program are included in Accounts Payable in the Consolidated Balance Sheets and within Operating Activities in the Consolidated Statements of Cash

------

<u>[**Table of Contents**](#i6f3afdd0c78149d790c8cca7c8f4ba04_10)</u>

Flows. Amounts due under the SCF program were $90 million and $7 million as of August 2, 2025 and February 1, 2025, respectively.

***Concentration of Credit Risk***

The Company maintains cash and cash equivalents and derivative contracts with various major financial institutions. The Company monitors the relative credit standing of financial institutions with whom it transacts and limits the amount of credit exposure with any one entity. The Company's investment portfolio is primarily composed of U.S. government obligations, U.S. Treasury and AAA-rated money market funds, commercial paper and bank deposits.

The Company also periodically reviews the relative credit standing of franchise, license and wholesale partners and other entities to which it grants credit terms in the normal course of business. The Company determines the required allowance for expected credit losses using information such as customer credit history and financial condition. Amounts are recorded to the allowance when it is determined that expected credit losses may occur.

***Easton Investments***

The Company has land and other investments in Easton, a planned community in Columbus, Ohio, that integrates office, hotel, retail, residential and recreational space. Beginning in the fourth quarter of 2024, certain of these investments met all of the required criteria for held for sale presentation, which requires assets to be reported at the lower of their carrying value or fair value less costs to sell. The investments classified as held for sale, consisting primarily of undeveloped land, are reported at their carrying value, which was $81 million and $96 million as of August 2, 2025 and February 1, 2025, respectively, within Current Assets on the Consolidated Balance Sheets.

During the second quarter of 2025, the Company changed its plan of sale for its Easton investments, causing certain of these investments to no longer meet the held for sale criteria. As a result of this change, the Company reclassified $17 million of carrying value from Current Assets to long-term Other Assets on the August 2, 2025 Consolidated Balance Sheet. Following this reclassification, the Company's Easton investments not presented as held for sale were $40 million and reported in Other Assets as of August 2, 2025. The Company's Easton investments not presented as held for sale and reported in Other Assets were $26 million as of February 1, 2025 and $121 million as of August 3, 2024.

Previously included in the Company's Easton investments were equity interests in Easton Town Center, LLC ("ETC") and Easton Gateway, LLC ("EG"), entities that own and develop commercial entertainment and shopping centers. The Company's investments in ETC and EG were accounted for using the equity method of accounting. In the second quarter of 2024, the Company sold its entire interest in the business associated with EG and its entire interest in ETC. The Company received aggregate cash proceeds of $50 million at the closing of these sales, and recognized a pre-tax gain of $39 million, which is included in Other Income, Net, in the 2024 Consolidated Statements of Income.

***Use of Estimates in the Preparation of Financial Statements***

The preparation of financial statements in conformity with U.S. generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period, as well as the related disclosure of contingent assets and liabilities at the date of the financial statements. Actual results may differ from those estimates, and the Company revises its estimates and assumptions as new information becomes available.

***Recently Issued Accounting Pronouncements***

In December 2023, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU") 2023-09, *Improvements to Income Tax Disclosures*, that requires enhanced income tax disclosures, primarily related to standardization and disaggregation of rate reconciliation categories and income taxes paid by jurisdiction. This standard is effective for fiscal years beginning after December 15, 2024, with early adoption permitted, and may be applied either prospectively or retrospectively. The Company is currently evaluating the impact of adopting this standard on its disclosures.

In November 2024, the FASB issued ASU 2024-03, *Disaggregation of Income Statement Expenses*, that requires disclosures of disaggregated information about certain prescribed expense categories within relevant income statement expense captions. This standard is effective for annual reporting of fiscal years beginning after December 15, 2026, and for interim periods in the following year, with early adoption permitted. This standard should be applied prospectively, with retrospective application permitted. The Company is currently evaluating the impact of adopting this standard on its disclosures.

**2. Revenue Recognition**

Accounts receivable, net from revenue-generating activities were $75 million as of August 2, 2025, $81 million as of February 1, 2025 and $87 million as of August 3, 2024. These accounts receivable primarily relate to amounts due from the Company's franchise, license and wholesale partners. Under these arrangements, payment terms are typically 45 to 75 days.

------

<u>[**Table of Contents**](#i6f3afdd0c78149d790c8cca7c8f4ba04_10)</u>

The Company records deferred revenue when cash payments are received in advance of transfer of control of goods or services. Deferred revenue primarily relates to gift cards, loyalty points and rewards, and direct channel shipments not received by the customer, which are all impacted by seasonal and holiday-related sales patterns. Deferred revenue, which is recorded within Accrued Expenses and Other on the Consolidated Balance Sheets, was $172 million as of August 2, 2025, $197 million as of February 1, 2025 and $166 million as of August 3, 2024. The Company recognized $87 million as revenue year-to-date 2025 from amounts recorded as deferred revenue at the beginning of the Company's fiscal year.

The following table provides a disaggregation of Net Sales for the second quarters of and year-to-date 2025 and 2024:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Second Quarter** | **Second Quarter** | **Year-to-Date** | **Year-to-Date** |
| | **2025** | **2024** | **2025** | **2024** |
| | **(in millions)** | **(in millions)** | **(in millions)** | **(in millions)** |
| Stores - U.S. and Canada (a) | $1196 | $1140 | $2307 | $2205 |
| Direct - U.S. and Canada | 267 | 297 | 517 | 558 |
| International (b) | 86 | 89 | 150 | 147 |
| **Total Net Sales** | $1549 | $1526 | $2974 | $2910 |

---

_______________

(a)Results include fulfilled buy online pick up in store orders.

(b)Results include royalties associated with franchised stores and wholesale sales.

The Company's Net Sales outside of the U.S. include sales from Company-operated stores and its e-commerce site in Canada, royalties associated with franchised stores and wholesale sales. Certain of these sales are subject to the impact of fluctuations in foreign currency. The Company's Net Sales outside of the U.S. totaled $167 million and $164 million for the second quarters of 2025 and 2024, respectively, and $299 million and $289 million for year-to-date 2025 and 2024, respectively.

**3. Net Income Per Share and Shareholders' Equity (Deficit)**

***Net Income Per Share***

Net Income per Basic Share is computed based on the weighted-average number of common shares outstanding. Net Income per Diluted Share includes the weighted-average effect of dilutive restricted share units, performance share units and stock options (collectively, "Dilutive Awards") on the weighted-average common shares outstanding.

The following table provides the weighted-average shares utilized for the calculation of Net Income per Basic and Diluted Share for the second quarters of and year-to-date 2025 and 2024:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Second Quarter** | **Second Quarter** | **Year-to-Date** | **Year-to-Date** |
| | **2025** | **2024** | **2025** | **2024** |
| | **(in millions)** | **(in millions)** | **(in millions)** | **(in millions)** |
| Common Shares | 225 | 237 | 227 | 239 |
| Treasury Shares | (15) | (15) | (15) | (15) |
| &nbsp;&nbsp;&nbsp;&nbsp;**Basic Shares** | 210 | 222 | 212 | 224 |
| Effect of Dilutive Awards | 1 | 1 | 1 | 1 |
| &nbsp;&nbsp;&nbsp;&nbsp;**Diluted Shares** | 211 | 223 | 213 | 225 |
| Anti-dilutive Awards (a) |  |  |  | 1 |

---

_______________

(a)These awards were excluded from the calculation of Net Income per Diluted Share because their inclusion would have been anti-dilutive.

------

<u>[**Table of Contents**](#i6f3afdd0c78149d790c8cca7c8f4ba04_10)</u>

***Common Stock Repurchases and Retirements***

Under the authority of the Company's Board of Directors, the Company repurchased shares of its common stock under the following repurchase programs during year-to-date 2025 and 2024:

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
| **Repurchase <br>Program** | **Amount<br>Authorized** | **Shares<br>Repurchased** | **Shares<br>Repurchased** | **Amount<br>Repurchased** | **Amount<br>Repurchased** | **Average Stock Price** | **Average Stock Price** |
| **Repurchase <br>Program** | **Amount<br>Authorized** | **2025** | **2024** | **2025** | **2024** | **2025** | **2024** |
| | **(in millions)** | **(in thousands)** | **(in thousands)** | **(in millions)** | **(in millions)** | | |
| February 2022 | $1500 | NA | 842 | NA | $39 | NA | $46.08 |
| January 2024 | 500 | 460 | 4921 | $17 | 210 | $37.67 | 42.72 |
| January 2025 | 500 | 8008 | NA | 239 | NA | 29.78 | NA |
| **Total** |  | 8468 | 5763 | $256 | $249 |  |  |

---

The January 2024 Program had $139 million of remaining authority as of February 1, 2025. There were share repurchases of $1 million as of February 1, 2025 and $2 million as of August 3, 2024 reflected in Accounts Payable on the Consolidated Balance Sheets.

On February 27, 2025, the Company cancelled the remaining $121 million authorization available under the January 2024 Program and began repurchasing shares under the January 2025 Program. There were share repurchases of $3 million as of August 2, 2025 reflected in Accounts Payable on the Consolidated Balance Sheet. The January 2025 Program had $262 million of remaining authority as of August 2, 2025.

Shares repurchased under these programs are retired and cancelled upon repurchase. As a result, the Company retired the 8.468 million and 5.763 million shares repurchased during year-to-date 2025 and 2024, respectively.

***Dividends***

The Company paid the following dividends during the first and second quarters of 2025 and 2024:

---

| | | |
|:---|:---|:---|
| | **Ordinary Dividends** | **Total Paid** |
| | **(per share)** | **(in millions)** |
| **2025** |  |  |
| First Quarter | $0.20 | $43 |
| Second Quarter | 0.20 | 42 |
| **Total** | $0.40 | $85 |
| **2024** |  |  |
| First Quarter | $0.20 | $45 |
| Second Quarter | 0.20 | 45 |
| **Total** | $0.40 | $90 |

---

In August 2025, the Company declared its third quarter 2025 ordinary dividend of $0.20 per share payable on September 5, 2025 to shareholders of record at the close of business on August 22, 2025.

**4. Inventories**

The following table provides details of Inventories as of August 2, 2025, February 1, 2025 and August 3, 2024:

---

| | | | |
|:---|:---|:---|:---|
| | **August 2,<br>2025** | **February 1,<br>2025** | **August 3,<br>2024** |
| | **(in millions)** | **(in millions)** | **(in millions)** |
| Finished Goods Merchandise | $724 | $589 | $669 |
| Raw Materials and Merchandise Components | 253 | 145 | 194 |
| **Total Inventories** | $977 | $734 | $863 |

---

Inventories are principally valued at the lower of cost or net realizable value, on an average cost basis.

------

<u>[**Table of Contents**](#i6f3afdd0c78149d790c8cca7c8f4ba04_10)</u>

**5. Long-lived Assets**

The following table provides details of Property and Equipment, Net as of August 2, 2025, February 1, 2025 and August 3, 2024:

---

| | | | |
|:---|:---|:---|:---|
| | **August 2,<br>2025** | **February 1,<br>2025** | **August 3,<br>2024** |
| | **(in millions)** | **(in millions)** | **(in millions)** |
| Property and Equipment, at Cost | $3310 | $3217 | $3171 |
| Accumulated Depreciation and Amortization | (2186) | (2090) | (2005) |
| **Property and Equipment, Net** | $1124 | $1127 | $1166 |

---

Depreciation expense was $64 million and $71 million for the second quarters of 2025 and 2024, respectively. Depreciation expense was $128 million and $142 million for year-to-date 2025 and 2024, respectively. Capital Expenditures of $51 million and $24 million remained unpaid as of August 2, 2025 and February 1, 2025, respectively.

**6. Income Taxes**

The provision for income taxes is based on the current estimate of the annual effective tax rate and is adjusted as necessary for quarterly events.

For the second quarter of 2025, the Company's effective tax rate was 32.3% compared to 0.9% in the second quarter of 2024. The 2025 second quarter rate was higher than the Company's combined estimated federal and state statutory rates largely due to the transition of certain members of the leadership team, primarily related to severance benefits. The 2024 second quarter rate was lower than the Company's combined estimated federal and state statutory rates primarily due to the sales of Easton investments during the quarter, which resulted in the release of a valuation allowance on a deferred tax asset.

For year-to-date 2025, the Company's effective tax rate was 29.9% compared to 12.1% for year-to-date 2024. The 2025 year-to-date rate was higher than the Company's combined estimated federal and state statutory rates largely due to accrued interest expense related to unrecognized tax benefits and the transition of certain members of the leadership team, primarily related to severance benefits. The 2024 year-to-date rate was lower than the Company's combined estimated federal and state statutory rates primarily due to the sales of Easton investments during the period, which resulted in the release of a valuation allowance on a deferred tax asset.

Income taxes paid were $207 million and $203 million for year-to-date 2025 and 2024, respectively.

On July 4, 2025, H.R.1 was enacted in the U.S., which includes various tax reform provisions, including extending and modifying certain key Tax Cuts and Jobs Act provisions, and provisions allowing accelerated tax deductions for qualified property and research expenditures. This legislation did not have a material impact to the Company's results of operations, financial condition or cash flows as of and for the twenty-six week period ended August 2, 2025.

------

<u>[**Table of Contents**](#i6f3afdd0c78149d790c8cca7c8f4ba04_10)</u>

**7. Long-term Debt and Borrowing Facility**

The following table provides the Company's outstanding Long-term Debt balances, net of unamortized debt issuance costs and discounts, as of August 2, 2025, February 1, 2025 and August 3, 2024:

---

| | | | |
|:---|:---|:---|:---|
| | **August 2,<br>2025** | **February 1,<br>2025** | **August 3,<br>2024** |
| | **(in millions)** | **(in millions)** | **(in millions)** |
| **<u>Senior Debt with Subsidiary Guarantee</u>** | | | |
| $500 million, 9.375% Fixed Interest Rate Notes due July 2025 ("2025 Notes") | $— | $— | $313 |
| $284 million, 6.694% Fixed Interest Rate Notes due January 2027 ("2027 Notes") | 278 | 277 | 275 |
| $444 million, 5.250% Fixed Interest Rate Notes due February 2028 ("2028 Notes") | 443 | 443 | 443 |
| $482 million, 7.500% Fixed Interest Rate Notes due June 2029 ("2029 Notes") | 477 | 476 | 475 |
| $844 million, 6.625% Fixed Interest Rate Notes due October 2030 ("2030 Notes") | 839 | 838 | 838 |
| $802 million, 6.875% Fixed Interest Rate Notes due November 2035 ("2035 Notes") | 797 | 796 | 796 |
| $575 million, 6.750% Fixed Interest Rate Notes due July 2036 ("2036 Notes") | 571 | 571 | 571 |
| Total Senior Debt with Subsidiary Guarantee | 3405 | 3401 | 3711 |
| **<u>Senior Debt</u>** |  |  |  |
| $284 million, 6.950% Fixed Interest Rate Debentures due March 2033 ("2033 Notes") | 283 | 283 | 283 |
| $201 million, 7.600% Fixed Interest Rate Notes due July 2037 ("2037 Notes") | 200 | 200 | 200 |
| Total Senior Debt | 483 | 483 | 483 |
| **Total Debt** | 3888 | 3884 | 4194 |
| Current Debt |  |  | (313) |
| **Total Long-term Debt, Net of Current Portion** | $3888 | $3884 | $3881 |

---

Cash paid for interest was $143 million and $152 million for year-to-date 2025 and 2024, respectively.

***Repurchases of Notes***

The Company did not repurchase any outstanding senior notes during the second quarter of and year-to-date 2025.

During the second quarter of and year-to-date 2024, the Company repurchased in the open market and extinguished $91 million and $200 million principal amounts of its outstanding senior notes, respectively. The aggregate repurchase price for these notes was $92 million and $202 million for the second quarter of and year-to-date 2024, respectively, resulting in pre-tax losses of $2 million and $3 million, including the write-off of unamortized issuance costs, during the second quarter of and year-to-date 2024, respectively. These losses are included in Other Income, Net, in the 2024 Consolidated Statements of Income.

The following table provides details of the outstanding principal amounts of senior notes repurchased and extinguished during the second quarter, year-to-date and full year of 2024:

---

| | | | |
|:---|:---|:---|:---|
| | **Second Quarter** | **Year-to-Date** | **Full Year** |
| | **(in millions)** | **(in millions)** | **(in millions)** |
| 2025 Notes | $— | $— | $314 |
| 2027 Notes | 14 | 14 | 14 |
| 2028 Notes | 7 | 17 | 17 |
| 2029 Notes | 10 | 17 | 17 |
| 2030 Notes | 56 | 94 | 94 |
| 2033 Notes |  | 10 | 10 |
| 2035 Notes | 4 | 10 | 10 |
| 2036 Notes |  | 38 | 38 |
| **Total** | $91 | $200 | $514 |

---

***Asset-backed Revolving Credit Facility***

The Company and certain of the Company's 100% owned subsidiaries guarantee and pledge collateral to secure an asset-backed revolving credit facility ("ABL Facility"). The ABL Facility, which allows borrowings and letters of credit in U.S. and Canadian dollars, has aggregate commitments of $750 million.

------

<u>[**Table of Contents**](#i6f3afdd0c78149d790c8cca7c8f4ba04_10)</u>

In May 2025, the Company entered into an amendment and restatement ("Amendment") of the ABL Facility. The Amendment removed the interest rate credit spread adjustment of 0.10%, extended the expiration date from August 2026 to May 2030 and included certain other technical amendments.

Availability under the ABL Facility is the lesser of (i) the borrowing base, determined primarily based on the Company's eligible U.S. and Canadian credit card receivables, accounts receivable, inventory and eligible real property, or (ii) the aggregate commitment. If at any time the outstanding amount under the ABL Facility exceeds the lesser of (i) the borrowing base and (ii) the aggregate commitment, the Company is required to repay the outstanding amounts under the ABL Facility to the extent of such excess. As of August 2, 2025, the Company's borrowing base was $683 million, and it had no borrowings outstanding under the ABL Facility.

The ABL Facility supports the Company's letter of credit program. The Company had $9 million of outstanding letters of credit as of August 2, 2025 that reduced its availability under the ABL Facility. As of August 2, 2025, the Company's availability under the ABL Facility was $674 million.

As of August 2, 2025, the ABL Facility fees related to committed and unutilized amounts were 0.30% per annum, and the fees related to outstanding letters of credit were 1.25% per annum. In addition, the interest rate on outstanding U.S. dollar borrowings was the Term Secured Overnight Financing Rate plus 1.25% per annum. The interest rate on outstanding Canadian dollar-denominated borrowings was the Canadian Overnight Repo Rate Average plus 1.25% per annum.

The ABL Facility requires the Company to maintain a fixed charge coverage ratio of not less than 1.00 to 1.00 during an event of default or any period commencing on any day when specified excess availability is less than the greater of (i) $70 million or (ii) 10% of the maximum borrowing amount. As of August 2, 2025, the Company was not required to maintain this ratio.

**8. Fair Value Measurements**

Cash and Cash Equivalents include cash on hand, deposits with financial institutions and highly liquid investments with original maturities of less than 90 days. The Company's Cash and Cash Equivalents are considered Level 1 fair value measurements as they are valued using unadjusted quoted prices in active markets for identical assets.

The following table provides a summary of the principal value and estimated fair value of the Company's outstanding debt as of August 2, 2025, February 1, 2025 and August 3, 2024:

---

| | | | |
|:---|:---|:---|:---|
| | **August 2,<br>2025** | **February 1,<br>2025** | **August 3,<br>2024** |
| | **(in millions)** | **(in millions)** | **(in millions)** |
| Principal Value | $3916 | $3916 | $4230 |
| Fair Value, Estimated (a) | 3992 | 3986 | 4241 |

---

_______________

(a)The estimated fair value of the Company's debt is based on reported transaction prices, which are considered Level 2 inputs in accordance with Accounting Standards Codification 820, *Fair Value Measurement*. The estimates presented are not necessarily indicative of the amounts that the Company could realize in a current market exchange.

Management believes that the carrying values of the Company's Accounts Receivable, Accounts Payable and Accrued Expenses approximate their fair values because of their short maturities.

**9. Commitments and Contingencies**

The Company is subject to various claims and contingencies related to lawsuits, taxes, insurance, regulatory and other matters arising in the ordinary course of business. Actions filed against the Company from time to time may include commercial, tort, intellectual property, tax, customer, employment, wage and hour, data privacy, securities, anti-corruption and other claims, including purported class action lawsuits. Management believes that the ultimate liability arising from such claims and contingencies, if any, is not likely to have a material adverse effect on the Company's results of operations, financial condition or cash flows.

***Lease Guarantees***

In connection with the spin-off of Victoria's Secret & Co., the Company had remaining contingent obligations of $224 million as of August 2, 2025 related to lease payments under the current terms of noncancelable leases, primarily related to office space, expiring at various dates through 2037. These obligations include minimum rent and additional payments covering taxes, common area costs and certain other expenses and relate to leases that commenced prior to the spin-off. The Company's reserves related to these obligations were not significant for any period presented.

------

<u>[**Table of Contents**](#i6f3afdd0c78149d790c8cca7c8f4ba04_10)</u>

**10. Segment Reporting** 

The Company is managed at the consolidated level and therefore operates and reports as a single segment. During the second quarter of 2025, the Company's Chief Executive Officer was its Chief Operating Decision Maker ("CODM"), and the measure of profitability included in the financial information regularly provided to the CODM was total Company Adjusted Operating Income, or Operating Income in periods where there are no adjustments. The Company's CODM assesses Adjusted Operating Income performance in comparison to forecasts and historical results to make decisions on the reinvestment of profits into the business and capital allocation strategies.

The following table illustrates significant segment expenses that were regularly provided to the CODM for the second quarters of and year-to-date 2025 and 2024:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Second Quarter** | **Second Quarter** | **Year-to-Date** | **Year-to-Date** |
| | **2025** | **2024** | **2025** | **2024** |
| | **(in millions)** | **(in millions)** | **(in millions)** | **(in millions)** |
| Net Sales | $1549 | $1526 | $2974 | $2910 |
| Cost of Goods Sold | (631) | (623) | (1140) | (1131) |
| Buying and Occupancy | (278) | (277) | (547) | (546) |
| Gross Profit | 640 | 626 | 1287 | 1233 |
| Selling Expenses | (282) | (261) | (538) | (508) |
| Marketing Expenses | (53) | (51) | (103) | (95) |
| Adjusted General and Administrative Expenses | (133) | (131) | (264) | (260) |
| **Adjusted Operating Income** | 172 | 183 | 382 | 370 |
| Leadership Transition Costs (a) | (15) |  | (15) |  |
| **Reported Operating Income** | $157 | $183 | $367 | $370 |

---

________________

(a)In the second quarter of and year-to-date 2025, the Company recognized pre-tax costs of $15 million due to the transition of certain members of the leadership team, primarily related to severance benefits, which were excluded from General and Administrative Expenses in the Adjusted Operating Income details provided to the CODM.

As a single reportable segment entity, the other disclosures required by ASC 280, *Segment Reporting,* can be found in the Company's Consolidated Financial Statements and the Notes thereto, including the Company's measure of segment assets, which is total consolidated assets.

------

<u>[**Table of Contents**](#i6f3afdd0c78149d790c8cca7c8f4ba04_10)</u>

Report of Independent Registered Public Accounting Firm

To the Shareholders and Board of Directors of Bath & Body Works, Inc.

**Results of Review of Interim Financial Statements** 

We have reviewed the accompanying consolidated balance sheets of Bath & Body Works, Inc. (the Company) as of August 2, 2025 and August 3, 2024, the related consolidated statements of income, comprehensive income, and total equity (deficit) for the thirteen and twenty-six week periods ended August 2, 2025 and August 3, 2024, the consolidated statements of cash flows for the twenty-six week periods ended August 2, 2025 and August 3, 2024, and the related notes (collectively referred to as the "consolidated interim financial statements"). Based on our reviews, we are not aware of any material modifications that should be made to the consolidated interim financial statements for them to be in conformity with U.S. generally accepted accounting principles.

We have previously audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the consolidated balance sheet of the Company as of February 1, 2025, and the related consolidated statements of income, comprehensive income, total equity (deficit), and cash flows for the year then ended, and the related notes (not presented herein); and in our report dated March 14, 2025, we expressed an unqualified audit opinion on those consolidated financial statements. In our opinion, the information set forth in the accompanying consolidated balance sheet as of February 1, 2025, is fairly stated, in all material respects, in relation to the consolidated balance sheet from which it has been derived.

**Basis for Review Results**

These financial statements are the responsibility of the Company's management. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the SEC and the PCAOB. We conducted our review in accordance with the standards of the PCAOB. A review of interim financial statements consists principally of applying analytical procedures and making inquiries of persons responsible for financial and accounting matters. It is substantially less in scope than an audit conducted in accordance with the standards of the PCAOB, the objective of which is the expression of an opinion regarding the financial statements taken as a whole. Accordingly, we do not express such an opinion.

/s/ Ernst & Young LLP

Grandview Heights, Ohio

August 28, 2025

------

<u>[**Table of Contents**](#i6f3afdd0c78149d790c8cca7c8f4ba04_10)</u>

**SAFE HARBOR STATEMENT UNDER THE PRIVATE**

**SECURITIES LITIGATION ACT OF 1995**

We caution that any forward-looking statements (as such term is defined in the Private Securities Litigation Reform Act of 1995) contained in this report or made by our Company or our management involve risks and uncertainties and are subject to change based on various factors, many of which are beyond our control. Accordingly, our future performance and financial results may differ materially from those expressed or implied in any such forward-looking statements. Words such as "estimate," "project," "plan," "believe," "expect," "anticipate," "intend," "planned," "potential," "target," "goal" and any similar expressions may identify forward-looking statements. There are risks, uncertainties and other factors that in some cases have affected and, in the future, could affect our financial performance and actual results and could cause actual results to differ materially from those expressed or implied in any forward-looking statements included in this report or otherwise made by the Company or our management. These factors can be found in Item 1A. Risk Factors in our 2024 Annual Report on Form 10-K, and our subsequent filings.

We are not under any obligation and do not intend to make publicly available any update or other revisions to any of the forward-looking statements contained in this report to reflect circumstances existing after the date of this report or to reflect the occurrence of future events even if experience or future events make it clear that any expected results expressed or implied by those forward-looking statements will not be realized.

We announce material financial and operational information using our investor relations website, press releases, SEC filings and public conference calls and webcasts. Information about the Company, our business and our results of operations may also be announced by posts on our accounts on social media channels, including the following: Facebook, Instagram, X, LinkedIn, Pinterest, TikTok and YouTube. The information contained on, or that can be accessed through, our social media channels and our website is deemed not to be incorporated in this Quarterly Report on Form 10-Q or to be a part of this Quarterly Report on Form 10-Q. The information that we post through these social media channels and on our website may be deemed material. As a result, we encourage investors, the media and others interested in the Company to monitor these social media channels in addition to following our investor relations website, press releases, SEC filings and public conference calls and webcasts. The list of social media channels we use may be updated from time to time on our investor relations website.

**Item 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS** 

The following discussion and analysis of financial condition and results of operations is based upon our Consolidated Financial Statements, which have been prepared in accordance with accounting principles generally accepted in the United States of America ("GAAP") as codified in the Accounting Standards Codification. The following information should be read in conjunction with our financial statements and the related notes included in Part I, Item 1. Financial Statements in this Quarterly Report on Form 10-Q.

**Executive Overview** 

In the second quarter of 2025, total Net Sales were $1,549 million, which increased $23 million, or 1.5%, compared to the second quarter of 2024. Total North American Net Sales increased $26 million, primarily due to modest increases in transactions and average dollar sales, partially offset by a $3 million decline in International Net Sales. Our second quarter Operating Income was $157 million, which decreased $26 million, or 13.9%, compared to the second quarter of 2024, and our Operating Income rate (expressed as a percentage of Net Sales) decreased to 10.2% from 12.0%. The Operating Income rate decrease was primarily due to higher General, Administrative and Store Operating Expenses driven by leadership transition costs, partially offset by an increase in the Gross Profit rate.

For additional information related to our second quarter 2025 financial performance, see "Results of Operations."

**Outlook**

We expect consumers to remain cautious and value-seeking, with intentional purchasing behavior that prioritizes personal well-being and convenience, while spending selectively. We believe that our brand, stores, loyalty members, passionate store associates and a predominantly U.S. based vertically integrated supply chain form a strong foundation, and our investments in recent years have strengthened this foundation. In order to deliver durable and profitable growth and drive long-term shareholder value, we are taking swift action in the short-term while we actively shape our long-term strategy by making strategic moves that resonate with both current and future customers. We are focused on elevating our owned digital platform to meet the expectations of today's consumers by enhancing functionality and storytelling, which we believe will boost brand equity and direct channel sales. We are also amplifying our efficacy message by more clearly communicating claims and modernizing packaging to better reflect key product attributes, such as efficacy, safety, and emotional benefits, especially to younger and ingredient-conscious consumers, reinforcing the value of our products. Finally, we are focused on putting our product in the path of the consumer by strategically and thoughtfully exploring new forms of distribution beyond the owned channels we currently sell through to reach and engage new and younger consumers and drive brand discovery.

------

<u>[**Table of Contents**](#i6f3afdd0c78149d790c8cca7c8f4ba04_10)</u>

We expect consumer sentiment to remain volatile as the broad-based tariffs imposed by the U.S. government, and threatened or imposed retaliatory measures by other countries, have increased macroeconomic uncertainty in global markets and we are actively monitoring the changes in shifting trade policies and related market disruptions. We believe our vertically integrated, predominantly U.S. based supply chain positions us well to compete in the current environment and to absorb the impacts of tariffs at the existing levels in the current year. We also believe we have the ability to further mitigate these costs over time through strategic sourcing, operational efficiencies, and other targeted initiatives. Continued changes in trade policies and disruptions could have substantial impacts on the global economy and may magnify the impact of the risks to our business described in our Annual Report on Form 10-K.

**Adjusted Financial Information**

In addition to our results provided in accordance with GAAP above and throughout this Quarterly Report on Form 10-Q, provided below are non-GAAP measures that presents Operating Income, Net Income and Net Income Per Diluted Share for the second quarters of and year-to-date 2025 and 2024 on an adjusted basis to remove certain items. We believe that these items are not indicative of our operations due to their size and nature.

We use adjusted financial information as key performance measures for the purpose of evaluating performance internally. These non-GAAP measures are not intended to replace the presentation of our financial results in accordance with GAAP. Instead, we believe that the presentation of adjusted financial information provides additional information to investors to facilitate the comparison of past and present operations. Further, our definitions of adjusted financial information may differ from similarly titled measures used by other companies.

The table below reconciles our GAAP financial measures to our non-GAAP financial measures:

---

| | | | | |
|:---|:---|:---|:---|:---|
| **(in millions, except per share amounts)** | **Second Quarter** | **Second Quarter** | **Year-to-Date** | **Year-to-Date** |
|  | **2025** | **2024** | **2025** | **2024** |
| <u>Reconciliation of Reported Operating Income to Adjusted Operating Income</u> | <u>Reconciliation of Reported Operating Income to Adjusted Operating Income</u> | <u>Reconciliation of Reported Operating Income to Adjusted Operating Income</u> | <u>Reconciliation of Reported Operating Income to Adjusted Operating Income</u> |  |
| Reported Operating Income | $157 | $183 | $367 | $370 |
| Leadership Transition Costs (a) | 15 |  | 15 |  |
| Adjusted Operating Income | $172 | $183 | $382 | $370 |
| <u>Reconciliation of Reported Net Income to Adjusted Net Income</u> | <u>Reconciliation of Reported Net Income to Adjusted Net Income</u> | <u>Reconciliation of Reported Net Income to Adjusted Net Income</u> | <u>Reconciliation of Reported Net Income to Adjusted Net Income</u> |  |
| Reported Net Income | $64 | $152 | $169 | $239 |
| Leadership Transition Costs (a) | 15 |  | 15 |  |
| Gain on Sales of Easton Investments (b) |  | (39) |  | (39) |
| Tax Effect of Adjustments | (1) | 14 | (1) | 14 |
| Tax Benefit from Valuation Allowance Release (c) |  | (44) |  | (44) |
| Adjusted Net Income | $78 | $83 | $183 | $170 |
| <u>Reconciliation of Reported Net Income Per Diluted Share to Adjusted Net Income Per Diluted Share</u> | <u>Reconciliation of Reported Net Income Per Diluted Share to Adjusted Net Income Per Diluted Share</u> | <u>Reconciliation of Reported Net Income Per Diluted Share to Adjusted Net Income Per Diluted Share</u> | <u>Reconciliation of Reported Net Income Per Diluted Share to Adjusted Net Income Per Diluted Share</u> |  |
| Reported Net Income Per Diluted Share | $0.30 | $0.68 | $0.79 | $1.06 |
| Leadership Transition Costs (a) | 0.07 |  | 0.07 |  |
| Gain on Sales of Easton Investments (b) |  | (0.18) |  | (0.18) |
| Tax Effect of Adjustments | (0.01) | 0.06 | (0.01) | 0.06 |
| Tax Benefit from Valuation Allowance Release (c) |  | (0.20) |  | (0.19) |
| Adjusted Net Income Per Diluted Share | $0.37 | $0.37 | $0.86 | $0.76 |

---

________________

(a)In the second quarter of 2025, we recognized pre-tax costs of $15 million (after-tax costs of $14 million) due to the transition of certain members of the leadership team, primarily related to severance benefits.

(b)In the second quarter of 2024, we sold our investments in Easton Town Center and Easton Gateway, resulting in an aggregate pre-tax gain of $39 million (after-tax gain of $25 million). For additional information, see Note 1, "Description of Business and Basis of Presentation" included in Part I, Item 1. Financial Statements.

(c)In the second quarter of 2024, we recognized a $44 million tax benefit related to the release of a valuation allowance on a deferred tax asset.

------

<u>[**Table of Contents**](#i6f3afdd0c78149d790c8cca7c8f4ba04_10)</u>

**Company-operated Stores**

The following table compares Company-operated U.S. store data for the second quarters of and year-to-date 2025 and 2024:

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **Second Quarter** | **Second Quarter** | **Second Quarter** | **Year-to-Date** | **Year-to-Date** | **Year-to-Date** |
| | **2025** | **2024** | **% Change** | **2025** | **2024** | **% Change** |
| Sales per Average Selling Square Foot (a) | $220 | $216 | 2% | $427 | $420 | 2% |
| Sales per Average Store (in thousands) (a) | $627 | $613 | 2% | $1216 | $1188 | 2% |
| Average Store Size (selling square feet) | 2844 | 2833 | —% |  |  |  |
| Total Selling Square Feet (in thousands) | 5094 | 4989 | 2% |  |  |  |

---

________________

(a)Sales per average selling square foot and sales per average store, which are indicators of store productivity, are calculated based on store sales for the period divided by the average, including the beginning and end of period, of total selling square footage and store count, respectively.

The following table represents Company-operated store activity for year-to-date 2025:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Stores**<br>**February 1, 2025** |<br>**Opened** |<br>**Closed** | **Stores**<br>**August 2, 2025** |
| United States | 1782 | 33 | (24) | 1791 |
| Canada | 113 |  |  | 113 |
| **Total** | 1895 | 33 | (24) | 1904 |

---

**Partner-operated Stores**

The following table represents Partner-operated store activity for year-to-date 2025:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Stores**<br>**February 1, 2025** |<br>**Opened** |<br>**Closed** | **Stores**<br>**August 2, 2025** |
| International | 494 | 25 | (18) | 501 |
| International - Travel Retail | 35 | 3 | (2) | 36 |
| **Total International (a)** | 529 | 28 | (20) | 537 |

---

________________

(a)Includes store locations only and does not include kiosks, shop-in-shops, gondola or beauty counter locations.

**Results of Operations**

**Second Quarter of 2025 Compared to the Second Quarter of 2024**

***Net Sales***

The following table provides Net Sales for the second quarter of 2025 in comparison to the second quarter of 2024:

---

| | | | |
|:---|:---|:---|:---|
| | **2025** | **2024** | **% Change** |
| | **(in millions)** | **(in millions)** | |
| Stores - U.S. and Canada (a) | $1196 | $1140 | 4.9% |
| Direct - U.S. and Canada | 267 | 297 | (10.1%) |
| International (b) | 86 | 89 | (2.9%) |
| **Total Net Sales** | $1549 | $1526 | 1.5% |

---

_______________

(a)Results include fulfilled buy online pick up in store ("BOPIS") orders.

(b)Results include royalties associated with franchised stores and wholesale sales.

For the second quarter of 2025, total Net Sales were $1,549 million and increased $23 million, or 1.5%, compared to the second quarter of 2024. Stores Net Sales increased $56 million, or 4.9%, primarily driven by an increase in transactions due to an increase in BOPIS fulfilled orders (which are recognized as store Net Sales) and new store growth, and an increase in average dollar sales. Direct Net Sales decreased $30 million, or 10.1%, driven by a decline in fulfilled orders, which was primarily due to our customers continuing to select our BOPIS option, partially offset by an increase in average order size. International Net Sales decreased $3 million, or 2.9%.

------

<u>[**Table of Contents**](#i6f3afdd0c78149d790c8cca7c8f4ba04_10)</u>

***Gross Profit***

For the second quarter of 2025, our Gross Profit increased $14 million compared to the second quarter of 2024, to $640 million, and our Gross Profit rate (expressed as a percentage of Net Sales) increased to 41.3%, from 41.0% in the second quarter of 2024. Gross Profit dollars increased due to higher Net Sales, and the Gross Profit rate increased due to leverage on Occupancy Expenses largely driven by the exit of a third-party fulfillment center. The second quarter of 2025 merchandise margin rate was flat to the second quarter of 2024, as strategic pricing and strong cost management mitigated the impact from tariffs.

***General, Administrative and Store Operating Expenses***

The following table provides detail for our General, Administrative and Store Operating Expenses for the second quarter of 2025 compared to the second quarter of 2024:

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **2025** | **2025** | **2024** | **2024** | **Change** | **Change** |
| | **(in millions)** | **% of Net Sales** | **(in millions)** | **% of Net Sales** | **(in millions)** | **% of Net Sales** |
| Selling Expenses | $282 | 18.2% | $261 | 17.1% | $21 | 1.1% |
| Marketing Expenses | 53 | 3.4% | 51 | 3.3% | 3 | 0.1% |
| General and Administrative Expenses | 148 | 9.5% | 131 | 8.6% | 16 | 0.9% |
| **Total** | $483 | 31.1% | $443 | 29.1% | $40 | 2.0% |

---

For the second quarter of 2025, our total General, Administrative and Store Operating Expenses increased $40 million compared to the second quarter of 2024, to $483 million, and the rate (expressed as a percentage of Net Sales) increased to 31.1% from 29.1% in the second quarter of 2024. Selling Expenses increased primarily due to higher payroll related costs, mainly driven by investments in wages and new stores, and higher healthcare costs. General and Administrative Expenses increased primarily due to $15 million of costs related to the transition of certain members of the leadership team, primarily related to severance benefits.

The General, Administrative and Store Operating Expense rate increased primarily due to the leadership transition costs, increase in payroll related costs, and higher healthcare costs.

***Other Income and Expenses***

*Interest Expense*

The following table provides the average daily borrowings and average borrowing rates for the second quarters of 2025 and 2024:

---

| | | |
|:---|:---|:---|
| | **2025** | **2024** |
| Average daily borrowings (in millions) | $3916 | $4258 |
| Average borrowing rate | 7.1% | 7.3% |

---

For the second quarter of 2025, our Interest Expense was $68 million, compared to $77 million in the second quarter of 2024. The decrease was due to lower average daily borrowings and borrowing rate, which were driven by the early extinguishment of outstanding notes in fiscal year 2024.

*Other Income, Net*

For the second quarter of 2025, our Other Income, Net was $6 million, compared to $47 million in the second quarter of 2024. In the second quarter of 2024, Other Income, Net included an aggregate $39 million pre-tax gain on sales of certain Easton investments as well as a $2 million pre-tax loss on extinguishment of debt. The remaining decrease is primarily due to lower interest income on invested cash in the second quarter of 2025.

***Provision for Income Taxes***

For the second quarter of 2025, our effective tax rate was 32.3% compared to 0.9% in the second quarter of 2024. The 2025 second quarter rate was higher than our combined estimated federal and state statutory rates largely due to the transition of certain members of the leadership team, primarily related to severance benefits. The 2024 second quarter rate was lower than our combined estimated federal and state statutory rates primarily due to the sales of Easton investments during the quarter, which resulted in the release of a valuation allowance on a deferred tax asset.

**Results of Operations**

**Year-to-Date 2025 Compared to Year-to-Date 2024** 

For year-to-date 2025, Operating Income decreased $3 million to $367 million, from $370 million year-to-date 2024, and the Operating Income rate (expressed as a percentage of Net Sales) decreased to 12.3% from 12.7%. The drivers of the year-to-date Operating Income results are discussed in the following sections.

------

<u>[**Table of Contents**](#i6f3afdd0c78149d790c8cca7c8f4ba04_10)</u>

***Net Sales***

The following table provides Net Sales for year-to-date 2025 in comparison to year-to-date 2024:

---

| | | | |
|:---|:---|:---|:---|
| | **2025** | **2024** | **% Change** |
| | **(in millions)** | **(in millions)** | |
| Stores - U.S. and Canada (a) | $2307 | $2205 | 4.6% |
| Direct - U.S. and Canada | 517 | 558 | (7.4%) |
| International (b) | 150 | 147 | 2.3% |
| **Total Net Sales** | $2974 | $2910 | 2.2% |

---

_______________

(a)Results include fulfilled BOPIS orders.

(b)Results include royalties associated with franchised stores and wholesale sales.

For year-to-date 2025, Net Sales were $2,974 million and increased $64 million, or 2.2%, compared to year-to-date 2024. Stores Net Sales increased $102 million, or 4.6%, primarily driven by an increase in transactions due to an increase in BOPIS fulfilled orders (which are recognized as store Net Sales) and new store growth, and an increase in average dollar sales. Direct Net Sales decreased $41 million, or 7.4%, driven by a decline in fulfilled orders, which was primarily due to our customers continuing to select our BOPIS option, partially offset by an increase in average order size. International Net Sales increased $3 million, or 2.3%.

***Gross Profit***

For year-to-date 2025, our Gross Profit increased $54 million compared to year-to-date 2024, to $1,287 million, and our Gross Profit rate (expressed as a percentage of Net Sales) increased to 43.3% from 42.4% year-to-date 2024. Gross Profit dollars increased due to higher Net Sales as well as merchandise margin rate improvement, driven by strategic pricing and strong cost management partially offset by the impact from tariffs.

Gross Profit rate increased due to the merchandise margin rate improvement as well as leverage on Occupancy Expenses largely due to exit of a third-party fulfillment center and Net Sales growth.

***General, Administrative and Store Operating Expenses***

The following table provides detail for our General, Administrative and Store Operating Expenses for year-to-date 2025 compared to year-to-date 2024:

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **2025** | **2025** | **2024** | **2024** | **Change** | **Change** |
| | **(in millions)** | **% of Net Sales** | **(in millions)** | **% of Net Sales** | **(in millions)** | **% of Net Sales** |
| Selling Expenses | $538 | 18.1% | $508 | 17.5% | $30 | 0.6% |
| Marketing Expenses | 103 | 3.5% | 95 | 3.3% | 8 | 0.2% |
| General and Administrative Expenses | 279 | 9.4% | 260 | 8.9% | 19 | 0.5% |
| **Total** | $920 | 30.9% | $863 | 29.6% | $57 | 1.3% |

---

For year-to-date 2025, our General, Administrative and Store Operating Expenses increased $57 million compared to year-to-date 2024, to $920 million, and the rate (expressed as a percentage of Net Sales) increased to 30.9% from 29.6% year-to-date 2024. Selling Expenses increased primarily due to higher payroll related costs, mainly driven by investments in wages and new stores, and higher healthcare costs. General and Administrative Expenses increased primarily due to $15 million of costs related to the transition of certain members of the leadership team, primarily related to severance benefits, as well as associate wages.

The General, Administrative and Store Operating Expense rate increased primarily due to the increase in payroll related costs, leadership transition costs and higher healthcare costs as well as incremental investments in marketing.

***Other Income and Expenses***

*Interest Expense*

The following table provides the average daily borrowings and average borrowing rates for year-to-date 2025 and 2024:

---

| | | |
|:---|:---|:---|
| | **2025** | **2024** |
| Average daily borrowings (in millions) | $3916 | $4322 |
| Average borrowing rate | 7.1% | 7.3% |

---

------

<u>[**Table of Contents**](#i6f3afdd0c78149d790c8cca7c8f4ba04_10)</u>

For year-to-date 2025, our Interest Expense was $139 million, compared to $159 million for year-to-date 2024. The decrease was due to lower average daily borrowings and borrowing rate, which were driven by the early extinguishment of outstanding notes in fiscal year 2024.

*Other Income, Net*

For year-to-date 2025, our Other Income, Net was $13 million, compared to $61 million for year-to-date 2024. In year-to-date 2024, Other Income, Net included an aggregate $39 million pre-tax gain on sales of certain Easton investments as well as a $3 million pre-tax loss on extinguishment of debt. The remaining decrease is primarily due to lower interest income on invested cash in year-to-date 2025.

***Provision for Income Taxes***

For year-to-date 2025, our effective tax rate was 29.9% compared to 12.1% for year-to-date 2024. The 2025 year-to-date rate was higher than our combined estimated federal and state statutory rates largely due to accrued interest expense related to unrecognized tax benefits and the transition of certain members of the leadership team, primarily related to severance benefits. The 2024 year-to-date rate was lower than our combined estimated federal and state statutory rates primarily due to the sales of Easton investments, which resulted in the release of a valuation allowance on a deferred tax asset.

**FINANCIAL CONDITION**

**Liquidity and Capital Resources**

Liquidity, or access to cash, is an important factor in determining our financial stability. We are committed to maintaining adequate liquidity. Cash generated from our operating activities provides the primary resources to support current operations, growth initiatives, seasonal funding requirements, future common stock and debt repurchases, and capital expenditures. Our cash provided from operations is impacted by our net income and working capital changes. Our net income is impacted by, among other things, sales volume, seasonal sales patterns, success of new product introductions and product and market expansions, profit margins, income taxes and inflationary pressures. Typically, our sales are highest during the fourth quarter of the fiscal year due to seasonal and holiday-related sales patterns. Generally, our need for working capital peaks during the summer and fall months as inventory builds in anticipation of the holiday period. Our cash and cash equivalents held by foreign subsidiaries were $123 million as of August 2, 2025.

We repurchased 8.468 million shares of our common stock for $256 million during year-to-date 2025. We may, from time to time, repurchase, or otherwise retire, additional shares of our common stock or debt, as applicable.

We believe that our current cash position, our cash flows generated from operations and our borrowing capacity under our asset-backed revolving credit facility ("ABL Facility") will be sufficient to meet our liquidity needs, including capital expenditure requirements, for at least the next twelve months.

**Cash Flows**

The following table provides a summary of our cash flow activity during year-to-date 2025 and 2024:

---

| | | |
|:---|:---|:---|
| | **2025** | **2024** |
| | **(in millions)** | **(in millions)** |
| **Cash and Cash Equivalents, Beginning of Year** | $674 | $1084 |
| Net Cash Flows Provided by Operating Activities | 145 | 30 |
| Net Cash Flows Used for Investing Activities | (95) | (40) |
| Net Cash Flows Used for Financing Activities | (362) | (560) |
| Effects of Exchange Rate Changes on Cash and Cash Equivalents | 2 |  |
| Net Decrease in Cash and Cash Equivalents | (310) | (570) |
| **Cash and Cash Equivalents, End of Period** | $364 | $514 |

---

***Operating Activities***

Net cash provided by operating activities for year-to-date 2025 was $145 million, including net income of $169 million. Net income included depreciation of $128 million and share-based compensation expense of $18 million. Other changes in assets and liabilities represent items that had a current period cash flow impact, such as changes in working capital. The most significant items in working capital were the seasonal changes in Inventories, Income Taxes Payable and Accounts Receivable, with Inventories also impacted by the higher tariff levels in the current year. Accounts Payable, Accrued Expenses and Other provided a cash flow benefit primarily due to our efforts to improve working capital.

------

<u>[**Table of Contents**](#i6f3afdd0c78149d790c8cca7c8f4ba04_10)</u>

Net cash provided by operating activities for year-to-date 2024 was $30 million, including net income of $239 million. Net income included depreciation of $142 million, impacts to deferred income taxes of $102 million, an aggregate pre-tax gain on sales of certain Easton investments of $39 million and share-based compensation expense of $22 million. Other changes in assets and liabilities represent items that had a current period cash flow impact, such as changes in working capital. The most significant items in working capital were the seasonal changes in Inventories, Income Taxes Payable, and Accounts Receivable, and the change in Accounts Payable, Accrued Expenses and Other.

***Investing Activities***

Net cash used for investing activities for year-to-date 2025 was $95 million, primarily related to capital expenditures. The capital expenditures included approximately $60 million related to new off-mall stores and remodels of existing stores and approximately $20 million for various technology projects primarily to support the growth and profitability of our business.

Net cash used for investing activities for year-to-date 2024 was $40 million primarily related to capital expenditures of $101 million, partially offset by aggregate cash proceeds of $50 million related to the sales of certain Easton investments. The capital expenditures included approximately $75 million related to new, primarily off-mall, stores and remodels of existing stores, approximately $15 million for various technology projects primarily to support the growth and profitability of our business and approximately $10 million related to distribution and logistics capabilities.

In 2025, our top priority remains driving sustainable, long-term, profitable growth through strategic investments in the business. To support this, we continue to plan capital expenditures of approximately $250 million to $270 million during the year, with a focus on real estate and technology.

***Financing Activities***

Net cash used for financing activities during year-to-date 2025 was $362 million, primarily consisting of $254 million for share repurchases and dividend payments of $0.40 per share, or $85 million.

Net cash used for financing activities for year-to-date 2024 was $560 million, primarily consisting of $248 million for share repurchases, $202 million for open market debt repurchases, dividend payments of $0.40 per share, or $90 million and $15 million of tax payments related to share-based awards.

**Common Stock and Debt Repurchases**

Our Board of Directors (our "Board") will determine share and debt repurchase authorizations, giving consideration to our levels of profit and cash flow, capital requirements, current and forecasted liquidity, the restrictions placed upon us by our borrowing arrangements as well as financial and other conditions existing at the time. We use cash flow generated from operating and financing activities to fund our share and debt repurchase programs. The timing and amount of any repurchases will be made at our discretion, taking into account a number of factors, including market conditions.

***Common Stock Repurchases***

Under the authority of our Board of Directors, we repurchased shares of our common stock under the following repurchase programs during year-to-date 2025 and 2024:

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
| **Repurchase<br> Program** | **Amount<br>Authorized** | **Shares<br>Repurchased** | **Shares<br>Repurchased** | **Amount<br>Repurchased** | **Amount<br>Repurchased** | **Average Stock Price** | **Average Stock Price** |
| **Repurchase<br> Program** | **Amount<br>Authorized** | **2025** | **2024** | **2025** | **2024** | **2025** | **2024** |
| | **(in millions)** | **(in thousands)** | **(in thousands)** | **(in millions)** | **(in millions)** | | |
| February 2022 | $1500 | NA | 842 | NA | $39 | NA | $46.08 |
| January 2024 | 500 | 460 | 4921 | $17 | 210 | $37.67 | 42.72 |
| January 2025 | 500 | 8008 | NA | 239 | NA | 29.78 | NA |
| **Total** |  | 8468 | 5763 | $256 | $249 |  |  |

---

------

<u>[**Table of Contents**](#i6f3afdd0c78149d790c8cca7c8f4ba04_10)</u>

The January 2024 Program had $139 million of remaining authority as of February 1, 2025. There were share repurchases of $1 million as of February 1, 2025 and $2 million as of August 3, 2024 reflected in Accounts Payable on the Consolidated Balance Sheets.

On February 27, 2025, we cancelled the remaining $121 million authorization available under the January 2024 Program and began repurchasing shares under the January 2025 Program. There were share repurchases of $3 million as of August 2, 2025 reflected in Accounts Payable on the Consolidated Balance Sheet. The January 2025 Program had $262 million of remaining authority as of August 2, 2025.

**Dividend Policy and Procedures**

Our Board will determine future dividends after giving consideration to our levels of profit and cash flow, capital requirements, current and forecasted liquidity, the restrictions placed upon us by our borrowing arrangements as well as financial and other conditions existing at the time. We use cash flow generated from operating and financing activities to fund our dividends.

We paid the following dividends during the first and second quarters of 2025 and 2024:

---

| | | |
|:---|:---|:---|
| | **Ordinary Dividends** | **Total Paid** |
| | **(per share)** | **(in millions)** |
| **2025** |  |  |
| First Quarter | $0.20 | $43 |
| Second Quarter | 0.20 | 42 |
| **Total** | $0.40 | $85 |
| **2024** |  |  |
| First Quarter | $0.20 | $45 |
| Second Quarter | 0.20 | 45 |
| **Total** | $0.40 | $90 |

---

In August 2025, we declared our third quarter 2025 ordinary dividend of $0.20 per share payable on September 5, 2025 to shareholders of record at the close of business on August 22, 2025.

**Long-term Debt and Borrowing Facility**

The following table provides our outstanding Long-term Debt balances, net of unamortized debt issuance costs and discounts, as of August 2, 2025, February 1, 2025 and August 3, 2024:

---

| | | | |
|:---|:---|:---|:---|
| | **August 2,<br>2025** | **February 1,<br>2025** | **August 3,<br>2024** |
| | **(in millions)** | **(in millions)** | **(in millions)** |
| **<u>Senior Debt with Subsidiary Guarantee</u>** | | | |
| $500 million, 9.375% Fixed Interest Rate Notes due July 2025 ("2025 Notes") | $— | $— | $313 |
| $284 million, 6.694% Fixed Interest Rate Notes due January 2027 ("2027 Notes") | 278 | 277 | 275 |
| $444 million, 5.250% Fixed Interest Rate Notes due February 2028 ("2028 Notes") | 443 | 443 | 443 |
| $482 million, 7.500% Fixed Interest Rate Notes due June 2029 ("2029 Notes") | 477 | 476 | 475 |
| $844 million, 6.625% Fixed Interest Rate Notes due October 2030 ("2030 Notes") | 839 | 838 | 838 |
| $802 million, 6.875% Fixed Interest Rate Notes due November 2035 ("2035 Notes") | 797 | 796 | 796 |
| $575 million, 6.750% Fixed Interest Rate Notes due July 2036 ("2036 Notes") | 571 | 571 | 571 |
| Total Senior Debt with Subsidiary Guarantee | 3405 | 3401 | 3711 |
| **<u>Senior Debt</u>** |  |  |  |
| $284 million, 6.950% Fixed Interest Rate Debentures due March 2033 ("2033 Notes") | 283 | 283 | 283 |
| $201 million, 7.600% Fixed Interest Rate Notes due July 2037 ("2037 Notes") | 200 | 200 | 200 |
| Total Senior Debt | 483 | 483 | 483 |
| **Total Debt** | 3888 | 3884 | 4194 |
| Current Debt |  |  | (313) |
| **Total Long-term Debt, Net of Current Portion** | $3888 | $3884 | $3881 |

---

------

<u>[**Table of Contents**](#i6f3afdd0c78149d790c8cca7c8f4ba04_10)</u>

Cash paid for interest was $143 million and $152 million for year-to-date 2025 and 2024, respectively.

***Repurchases of Notes***

We did not repurchase any outstanding senior notes during the second quarter of and year-to-date 2025.

During the second quarter of and year-to-date 2024, we repurchased in the open market and extinguished $91 million and $200 million principal amounts of our outstanding senior notes, respectively. The aggregate repurchase price for these notes was $92 million and $202 million for the second quarter of and year-to-date 2024, respectively, resulting in pre-tax losses of $2 million and $3 million, including the write-off of unamortized issuance costs, during the second quarter of and year-to-date 2024, respectively. These losses are included in Other Income, Net in the 2024 Consolidated Statements of Income.

The following table provides details of the outstanding principal amounts of senior notes repurchased and extinguished during the second quarter, year-to-date and full year of 2024:

---

| | | | |
|:---|:---|:---|:---|
| | **Second Quarter** | **Year-to-Date** | **Full Year** |
| | **(in millions)** | **(in millions)** | **(in millions)** |
| 2025 Notes | $— | $— | $314 |
| 2027 Notes | 14 | 14 | 14 |
| 2028 Notes | 7 | 17 | 17 |
| 2029 Notes | 10 | 17 | 17 |
| 2030 Notes | 56 | 94 | 94 |
| 2033 Notes |  | 10 | 10 |
| 2035 Notes | 4 | 10 | 10 |
| 2036 Notes |  | 38 | 38 |
| **Total** | $91 | $200 | $514 |

---

***Asset-backed Revolving Credit Facility***

We and certain of our 100% owned subsidiaries guarantee and pledge collateral to secure the ABL Facility. The ABL Facility, which allows borrowings and letters of credit in U.S. and Canadian dollars, has aggregate commitments of $750 million.

In May 2025, we entered into an amendment and restatement ("Amendment") of the ABL Facility. The Amendment removed the interest rate credit spread adjustment of 0.10%, extended the expiration date from August 2026 to May 2030 and included certain other technical amendments.

Availability under the ABL Facility is the lesser of (i) the borrowing base, determined primarily based on our eligible U.S. and Canadian credit card receivables, accounts receivable, inventory and eligible real property, or (ii) the aggregate commitment. If at any time the outstanding amount under the ABL Facility exceeds the lesser of (i) the borrowing base and (ii) the aggregate commitment, we are required to repay the outstanding amounts under the ABL Facility to the extent of such excess. As of August 2, 2025, our borrowing base was $683 million, and we had no borrowings outstanding under the ABL Facility.

The ABL Facility supports our letter of credit program. We had $9 million of outstanding letters of credit as of August 2, 2025 that reduced our availability under the ABL Facility. As of August 2, 2025, our availability under the ABL Facility was $674 million.

As of August 2, 2025, the ABL Facility fees related to committed and unutilized amounts were 0.30% per annum, and the fees related to outstanding letters of credit were 1.25% per annum. In addition, the interest rate on outstanding U.S. dollar borrowings was the Term Secured Overnight Financing Rate plus 1.25% per annum. The interest rate on outstanding Canadian dollar-denominated borrowings was the Canadian Overnight Repo Rate Average plus 1.25% per annum.

The ABL Facility requires us to maintain a fixed charge coverage ratio of not less than 1.00 to 1.00 during an event of default or any period commencing on any day when specified excess availability is less than the greater of (i) $70 million or (ii) 10% of the maximum borrowing amount. As of August 2, 2025, we were not required to maintain this ratio.

**Credit Ratings**

The following table provides our credit ratings as of August 2, 2025:

---

| | | |
|:---|:---|:---|
| | **Moody's** | **S&P** |
| Corporate | Ba2 | BB+ |
| Senior Unsecured Debt with Subsidiary Guarantee | Ba2 | BB+ |
| Senior Unsecured Debt | B1 | BB- |
| Outlook | Stable | Stable |

---

------

<u>[**Table of Contents**](#i6f3afdd0c78149d790c8cca7c8f4ba04_10)</u>

**Guarantor Summarized Financial Information**

Certain of our subsidiaries, which are listed on Exhibit 22 to this Quarterly Report on Form 10-Q, have guaranteed our obligations under the 2027 Notes, 2028 Notes, 2029 Notes, 2030 Notes, 2035 Notes and 2036 Notes (collectively, the "Notes").

The Notes have been issued by Bath & Body Works, Inc. (the "Parent Company"). The Notes are its senior unsecured obligations and rank equally in right of payment with all of our existing and future senior unsecured obligations, are senior to any of our future subordinated indebtedness, are effectively subordinated to all of our existing and future indebtedness that is secured by a lien and are structurally subordinated to all existing and future obligations of each of our subsidiaries that do not guarantee the Notes.

The Notes are fully and unconditionally guaranteed on a joint and several basis by certain of our wholly-owned subsidiaries, including certain subsidiaries that also guarantee our obligations under our ABL Facility (such guarantees, the "Guarantees"; and, such guaranteeing subsidiaries, the "Subsidiary Guarantors"). The Guarantees of the Subsidiary Guarantors are subject to release in limited circumstances only upon the occurrence of certain customary conditions. Each Guarantee is limited, by its terms, to an amount not to exceed the maximum amount that can be guaranteed by the applicable Subsidiary Guarantor subject to avoidance under applicable fraudulent conveyance provisions of U.S. and non-U.S. law.

The following tables set forth summarized financial information for the Parent Company and the Subsidiary Guarantors on a combined basis after elimination of (i) intercompany transactions and balances among the Parent Company and the Subsidiary Guarantors and (ii) investments in and equity in the earnings of non-Guarantor subsidiaries.

---

| | | |
|:---|:---|:---|
| **SUMMARIZED BALANCE SHEETS** | **August 2,<br>2025** | **February 1,<br>2025** |
| | **(in millions)** | **(in millions)** |
| **ASSETS** | | |
| Current Assets (a) | $2031 | $2075 |
| Noncurrent Assets | 2441 | 2411 |
| **LIABILITIES** |  |  |
| Current Liabilities (b) | $2527 | $2394 |
| Noncurrent Liabilities (c) | 4941 | 4898 |

---

_______________

(a)Includes amounts due from non-Guarantor subsidiaries of $588 million and $572 million as of August 2, 2025 and February 1, 2025, respectively.

(b)Includes amounts due to non-Guarantor subsidiaries of $1.467 billion and $1.421 billion as of August 2, 2025 and February 1, 2025, respectively.

(c)Includes amounts due to non-Guarantor subsidiaries of $25 million as of August 2, 2025.

---

| | |
|:---|:---|
| **YEAR-TO-DATE 2025 SUMMARIZED STATEMENT OF INCOME** | **(in millions)** |
| Net Sales (a) | $2821 |
| Gross Profit | 1200 |
| Operating Income | 338 |
| Income Before Income Taxes | 210 |
| Net Income | 145 |

---

_______________

(a)Includes Net Sales of $72 million to non-Guarantor subsidiaries.

------

<u>[**Table of Contents**](#i6f3afdd0c78149d790c8cca7c8f4ba04_10)</u>

**Contingent Liabilities and Contractual Obligations**

***Lease Guarantees***

In connection with the spin-off of Victoria's Secret & Co., we had remaining contingent obligations of $224 million as of August 2, 2025 related to lease payments under the current terms of noncancelable leases, primarily related to office space, expiring at various dates through 2037. These obligations include minimum rent and additional payments covering taxes, common area costs and certain other expenses and relate to leases that commenced prior to the spin-off. Our reserves related to these obligations were not significant for any period presented.

***Contractual Obligations***

Our contractual obligations primarily consist of long-term debt and the related interest payments, operating leases, purchase orders for merchandise inventory and other long-term obligations. These contractual obligations impact our short-term and long-term liquidity and capital resource needs. There have been no material changes in our contractual obligations subsequent to February 1, 2025, as discussed in "Contingent Liabilities and Contractual Obligations" in our 2024 Annual Report on Form 10-K. Certain of our contractual obligations may fluctuate during the normal course of business (primarily changes in our merchandise inventory-related purchase obligations which fluctuate throughout the year as a result of the seasonal nature of our business).

**RECENTLY ISSUED ACCOUNTING PRONOUNCEMENTS**

In December 2023, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU") 2023-09, *Improvements to Income Tax Disclosures*, that requires enhanced income tax disclosures, primarily related to standardization and disaggregation of rate reconciliation categories and income taxes paid by jurisdiction. This standard is effective for fiscal years beginning after December 15, 2024, with early adoption permitted, and may be applied either prospectively or retrospectively. We are currently evaluating the impact of adopting this standard on our disclosures.

In November 2024, the FASB issued ASU 2024-03, *Disaggregation of Income Statement Expenses*, that requires disclosures of disaggregated information about certain prescribed expense categories within relevant income statement expense captions. This standard is effective for annual reporting of fiscal years beginning after December 15, 2026, and for interim periods in the following year, with early adoption permitted. This standard should be applied prospectively, with retrospective application permitted. We are currently evaluating the impact of adopting this standard on our disclosures.

**CRITICAL ACCOUNTING POLICIES AND ESTIMATES**

The preparation of financial statements in conformity with GAAP requires management to adopt accounting policies related to estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period, as well as the related disclosure of contingent assets and liabilities at the date of the financial statements. On an ongoing basis, management evaluates its accounting policies, estimates and judgments, including those related to inventories, valuation of long-lived store assets, claims and contingencies, income taxes and revenue recognition, including revenue associated with our loyalty program. Management bases our estimates and judgments on historical experience and various other factors that we believe are reasonable under the circumstances. Actual results may differ from these estimates.

There have been no material changes to the critical accounting policies and estimates disclosed in our 2024 Annual Report on Form 10-K.

**Item 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK**

**Market Risk**

The market risk inherent in our financial instruments represents the potential loss in fair value, earnings or cash flows arising from adverse changes in foreign currency exchange rates or interest rates. We may use derivative financial instruments like foreign currency forward contracts, cross-currency swaps and interest rate swap arrangements to manage exposure to market risks. We do not use derivative financial instruments for trading purposes.

***Foreign Exchange Rate Risk***

Our Canadian dollar denominated earnings are subject to exchange rate risk as substantially all our merchandise sold in Canada is sourced through U.S. dollar transactions. Although we utilize foreign currency forward contracts to partially offset risks associated with our operations in Canada, these measures may not succeed in offsetting all the short-term impact of foreign currency rate movements and generally may not be effective in offsetting the long-term impact of sustained shifts in foreign currency rates.

------

<u>[**Table of Contents**](#i6f3afdd0c78149d790c8cca7c8f4ba04_10)</u>

Further, although our royalty arrangements with our international partners are denominated in U.S. dollars, the royalties we receive in U.S. dollars are calculated based on sales in the local currency. As a result, our royalties in these arrangements are exposed to foreign currency exchange rate fluctuations.

***Interest Rate Risk***

Our investment portfolio primarily consists of interest-bearing instruments that are classified as cash and cash equivalents based on their original maturities. Our investment portfolio is maintained in accordance with our investment policy, which specifies permitted types of investments, specifies credit quality standards and maturity profiles and limits credit exposure to any single issuer. The primary objectives of our investment activities are the preservation of principal, the maintenance of liquidity and the maximization of interest income while minimizing risk. Our investment portfolio is primarily composed of U.S. government obligations, U.S. Treasury and AAA-rated money market funds, commercial paper and bank deposits. Given the short-term nature and quality of investments in our portfolio, we do not believe there is any material risk to principal associated with increases or decreases in interest rates.

All of our outstanding Long-term Debt as of August 2, 2025 has fixed interest rates. We will from time to time adjust our exposure to interest rate risk by entering into interest rate swap arrangements. Our exposure to interest rate changes is limited to the fair value of the debt issued, which would not have a material impact on our earnings or cash flows.

***Concentration of Credit Risk***

We maintain cash and cash equivalents and derivative contracts with various major financial institutions. We monitor the relative credit standing of financial institutions with whom we transact and limit the amount of credit exposure with any one entity. Our investment portfolio is primarily composed of U.S. government obligations, U.S. Treasury and AAA-rated money market funds, commercial paper and bank deposits. We also periodically review the relative credit standing of franchise, license and wholesale partners and other entities to which we grant credit terms in the normal course of business.

***Fair Value Measurements***

The following table provides a summary of the principal value and estimated fair value of our outstanding debt as of August 2, 2025, February 1, 2025 and August 3, 2024:

---

| | | | |
|:---|:---|:---|:---|
| | **August 2,<br>2025** | **February 1,<br>2025** | **August 3,<br>2024** |
| | **(in millions)** | **(in millions)** | **(in millions)** |
| Principal Value | $3916 | $3916 | $4230 |
| Fair Value, Estimated (a) | 3992 | 3986 | 4241 |

---

_______________

(a)&nbsp;&nbsp;&nbsp;&nbsp;The estimated fair values are based on reported transaction prices and are not necessarily indicative of the amounts that we could realize in a current market exchange.

As of August 2, 2025, we believe that the carrying values of our Accounts Receivable, Accounts Payable and Accrued Expenses approximate their fair values because of their short maturities.

**Item 4. CONTROLS AND PROCEDURES**

*Evaluation of disclosure controls and procedures.* As of the end of the period covered by this report, we carried out an evaluation, under the supervision and with the participation of our management, including our Chief Executive Officer and Chief Financial Officer, of the effectiveness of the design and operation of our disclosure controls and procedures, as such term is defined in Rules 13a-15(e) and 15d-15(e) of the Securities Exchange Act of 1934, as amended (the "Exchange Act"). Based upon that evaluation, our Chief Executive Officer and Chief Financial Officer concluded that as of the end of the period covered by this report, our disclosure controls and procedures were effective and designed to ensure that information required to be disclosed by us in reports we file or submit under the Exchange Act is (1) recorded, processed, summarized and reported within the time periods specified in Securities and Exchange Commission ("SEC") rules and forms, and (2) accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, to allow timely decisions regarding required disclosure.

*Changes in internal control over financial reporting.* There were no changes in our internal control over financial reporting that occurred in the second quarter of 2025 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

------

<u>[**Table of Contents**](#i6f3afdd0c78149d790c8cca7c8f4ba04_10)</u>

**PART II—OTHER INFORMATION**

**Item 1. LEGAL PROCEEDINGS**

We are a defendant in a variety of lawsuits arising in the ordinary course of business. Actions filed against the Company from time to time may include commercial, tort, intellectual property, tax, customer, employment, wage and hour, data privacy, securities, anti-corruption and other claims, including purported class action lawsuits. Although it is not possible to predict with certainty the eventual outcome of any litigation, in the opinion of management, our current legal proceedings are not expected to have a material adverse effect on our results of operations, financial condition or cash flows.

**Item 1A. RISK FACTORS**

The risk factors that affect our business and financial results are discussed in Item 1A. Risk Factors in our 2024 Annual Report on Form 10-K. We wish to caution the reader that the risk factors discussed in Item 1A. Risk Factors in our 2024 Annual Report on Form 10-K and those described elsewhere in this report or other SEC filings could cause actual results to differ materially from those stated in any forward-looking statements.

**Item 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS**

The following table provides the repurchases of our common stock during the second quarter of 2025:

---

| | | | | |
|:---|:---|:---|:---|:---|
| **<u>Fiscal Period</u>** | **Total<br>Number of<br>Shares<br>Purchased (a)** | **Average Price<br>Paid per<br>Share (b)** | **Total Number of Shares Purchased as Part of Publicly Announced Programs (c)** | **Maximum Number of Shares (or Approximate Dollar Value) that May Yet be Purchased Under the Programs (c)** |
| | **(in thousands)** | | **(in thousands)** | **(in thousands)** |
| May 2025 | 608 | $29.32 | 517 | $367301 |
| June 2025 | 2258 | 27.76 | 2252 | 304798 |
| July 2025 | 1382 | 31.50 | 1373 | 261510 |
| **Total** | 4248 |  | 4142 |  |

---

_______________

(a)The total number of shares repurchased includes shares repurchased as part of publicly announced programs, with the remainder relating to shares in connection with tax payments due upon vesting of associate restricted share and performance share unit awards and the use of our stock to pay the exercise price on associate stock options.

(b)The average price paid per share includes any broker commissions.

(c)For additional share repurchase program information, see Note 3, "Net Income Per Share and Shareholders' Equity (Deficit)" included in Part I, Item 1. Financial Statements.

**Item 3. DEFAULTS UPON SENIOR SECURITIES**

Not applicable.

**Item 4. MINE SAFETY DISCLOSURES**

Not applicable.

**Item 5. OTHER INFORMATION**

***Securities Trading Plans of Directors and Executive Officers***

None of our directors or executive officers adopted or terminated a "Rule 10b5-1 trading arrangement" or a "non-Rule 10b5-1 trading arrangement" (as such terms are defined in Item 408(c) of Regulation S-K) during the second quarter of 2025.

------

<u>[**Table of Contents**](#i6f3afdd0c78149d790c8cca7c8f4ba04_10)</u>

**Item 6. EXHIBITS**

---

| | |
|:---|:---|
| **<u>Exhibits</u>** |  |
| <u>[10.1](bbwi-202582_ex101.htm)</u> | <u>[Letter Agreement between the Company and Eva Boratto, dated July 21, 2025.](bbwi-202582_ex101.htm)</u> |
| <u>[15](bbwi-202582_ex15.htm)</u> | <u>[Letter regarding Unaudited Interim Financial Information regarding Incorporation of Report of Independent Registered Public Accounting Firm.](bbwi-202582_ex15.htm)</u> |
| <u>[22](bbwi-202582_ex22.htm)</u> | <u>[List of Guarantor Subsidiaries.](bbwi-202582_ex22.htm)</u> |
| <u>[31.1](bbwi-202582_ex311.htm)</u> | <u>[Section 302 Certification of CEO.](bbwi-202582_ex311.htm)</u> |
| <u>[31.2](bbwi-202582_ex312.htm)</u> | <u>[Section 302 Certification of CFO.](bbwi-202582_ex312.htm)</u> |
| <u>[32](bbwi-202582_ex32.htm)</u> | <u>[Section 906 Certification (by CEO and CFO).](bbwi-202582_ex32.htm)</u> |
| 101.INS | XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document. |
| 101.SCH | Inline XBRL Taxonomy Extension Schema Document. |
| 101.CAL | Inline XBRL Taxonomy Extension Calculation Linkbase Document. |
| 101.DEF | Inline XBRL Taxonomy Definition Linkbase Document. |
| 101.LAB | Inline XBRL Taxonomy Extension Label Linkbase Document. |
| 101.PRE | Inline XBRL Taxonomy Extension Presentation Linkbase Document. |
| 104 | Cover Page Interactive Data File (formatted as inline XBRL and contained in Exhibit 101). |

---

------

<u>[**Table of Contents**](#i6f3afdd0c78149d790c8cca7c8f4ba04_10)</u>

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

---

| | |
|:---|:---|
| BATH & BODY WORKS, INC. | BATH & BODY WORKS, INC. |
| (Registrant) | (Registrant) |
| By: | /s/ EVA C. BORATTO |
|  | Eva C. Boratto<br>Chief Financial Officer \* |

---

Date: August 28, 2025

\*&nbsp;&nbsp;&nbsp;&nbsp;Ms. Boratto is the principal financial officer and the principal accounting officer and has been duly authorized to sign on behalf of the Registrant.

## Exhibit 10.1

**Exhibit 10.1**

July 21, 2025

Eva Boratto

Address on file

Dear Eva:

Due to the leadership changes that occurred in 2025, this letter agreement amends the Work Model Designation and Relocation sections of the offer letter entered into between you and Bath & Body Works, Inc. (the "<u>Company</u>"), dated July 18, 2023.

**Position&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Chief Financial Officer

**Reporting to&nbsp;&nbsp;&nbsp;&nbsp;**Daniel Heaf, Chief Executive Officer

**Work Model Designation** 

Your position as Chief Financial Officer at Bath and Body Works Inc. is based in Columbus,Ohio. You are expected to travel to Columbus, Ohio on a weekly basis, with an average in-office presence of three days per week, consistent with your established practice over the past two years. At your request, you will not be required to fully relocate to Columbus, Ohio and will maintain your residence in Philadelphia, PA. You acknowledge and agree that all personal expenses related to your travel to Columbus—including, without limitation, ground and air transportation, lodging, meals and incidental cost—will be your sole financial responsibility. You are also responsible for any personal tax implications that may arise from this arrangement. This excludes any expenses associated with relocation assistance in accordance with the Company's relocation policy as outlined below. The original stipend to assist with expenses was discontinued on June 30, 2025.

**Relocation Benefits** 

We are extending the option for you to partially relocate to Columbus, Ohio no later than December 31, 2025. You will be eligible to receive partial relocation assistance in accordance with the provisions of the Company's relocation policy, including 6 months temporary housing. To receive relocation assistance and benefits, you must agree to the Company's Relocation Policy, which provides that if you voluntarily resign or you are terminated for Cause prior to the first anniversary of your relocation date, you will reimburse the Company for all costs related to your relocation.

This letter does not constitute an employment contract with you. As set forth in our associate handbook, your employment will be at-will.

All compensation, benefits, bonuses, equity awards, and other such programs are governed by and subject to the official plan documents, award agreements, and decisions of the Board of Directors of the Company and may be amended, modified, or withdrawn at any time.

Upon acceptance of this amended and restated offer, please sign this letter and return them via DocuSign.

We want your review of this offer to be hassle-free, so we are here to answer any questions you may have. Please contact Michaela Oliver at moliver@bbw.com, and she can help clarify any part of your offer amendment.

Sincerely,&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;I accept this offer by signing on,

<u>/s/ DANIEL HEAF</u> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>/s/ EVA BORATTO</u> 

**Daniel Heaf&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Eva Boratto

Chief Executive Officer

Bath & Body Works Inc.

## Ex-15

**Exhibit 15**

August 28, 2025

To the Shareholders and Board of Directors of Bath & Body Works, Inc.

We are aware of the incorporation by reference in the following Registration Statements of Bath & Body Works, Inc.:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1)Registration Statement (Form S-3 ASR No. 333-285833) of Bath & Body Works, Inc.,

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(2)Registration Statement (Form S-8 No. 333-265379) pertaining to the Bath & Body Works, Inc. Associate Stock Purchase Plan,

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(3)Registration Statement (Form S-8 No. 333-251226) pertaining to the L Brands, Inc. 2020 Stock Option and Performance Incentive Plan, and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(4)Registration Statement (Form S-8 No. 333-206787) pertaining to the L Brands, Inc. 2015 Stock Option and Performance Incentive Plan;

of our report dated August 28, 2025 relating to the unaudited consolidated interim financial statements of Bath & Body Works, Inc. that are included in its Form 10-Q for the quarter ended August 2, 2025.

/s/ Ernst & Young LLP

Grandview Heights, Ohio

## Ex-22

**Exhibit 22**

**List of Guarantor Subsidiaries**

The 2027 Notes, 2028 Notes, 2029 Notes, 2030 Notes, 2035 Notes and 2036 Notes are jointly and severally guaranteed on a full and unconditional basis by Bath & Body Works, Inc. (incorporated in Delaware) and the following 100% owned subsidiaries of Bath & Body Works, Inc. as of August 2, 2025:

---

| | |
|:---|:---|
| **Entity** | **Jurisdiction of Incorporation or Organization** |
| Bath & Body Works, LLC | Delaware |
| Bath & Body Works Brand Management, Inc. | Delaware |
| Bath & Body Works Direct, Inc. | Delaware |
| beautyAvenues, LLC | Delaware |
| Beauty Specialty Holding, LLC | Delaware |
| L Brands Service Company, LLC | Delaware |

---

## Exhibit 31.1

**Exhibit 31.1**

Section 302 Certification

I, Daniel Heaf, certify that:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.&nbsp;&nbsp;&nbsp;&nbsp;I have reviewed this report on Form 10-Q of Bath & Body Works, Inc.;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.&nbsp;&nbsp;&nbsp;&nbsp;Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.&nbsp;&nbsp;&nbsp;&nbsp;Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.&nbsp;&nbsp;&nbsp;&nbsp;The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.&nbsp;&nbsp;&nbsp;&nbsp;The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

---

| |
|:---|
| /s/ DANIEL HEAF |
| Daniel Heaf |
| Chief Executive Officer |

---

Date: August 28, 2025

## Exhibit 31.2

**Exhibit 31.2**

Section 302 Certification

I, Eva C. Boratto, certify that:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.&nbsp;&nbsp;&nbsp;&nbsp;I have reviewed this report on Form 10-Q of Bath & Body Works, Inc.;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.&nbsp;&nbsp;&nbsp;&nbsp;Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.&nbsp;&nbsp;&nbsp;&nbsp;Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.&nbsp;&nbsp;&nbsp;&nbsp;The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.&nbsp;&nbsp;&nbsp;&nbsp;The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

---

| |
|:---|
| /s/ EVA C. BORATTO |
| Eva C. Boratto |
| Chief Financial Officer |

---

Date: August 28, 2025

## Ex-32

**Exhibit 32**

Section 906 Certification

Daniel Heaf, the Chief Executive Officer, and Eva C. Boratto, the Chief Financial Officer, of Bath & Body Works, Inc. (the "Company"), each certifies that, to the best of our knowledge:

(i)the Quarterly Report of the Company on Form 10-Q dated August 28, 2025 for the period ending August 2, 2025 (the "Form 10-Q"), fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(ii)the information contained in the Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of the Company.

---

| |
|:---|
| /s/ DANIEL HEAF |
| Daniel Heaf |
| Chief Executive Officer |
| /s/ EVA C. BORATTO |
| Eva C. Boratto |
| Chief Financial Officer |

---

Date: August 28, 2025

<br>